<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="ame212477" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Animal Model Exp Med</journal-id><journal-id journal-id-type="iso-abbrev">Animal Model Exp Med</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2576-2095</journal-id><journal-id journal-id-type="publisher-id">AME2</journal-id><journal-title-group><journal-title>Animal Models and Experimental Medicine</journal-title></journal-title-group><issn pub-type="ppub">2096-5451</issn><issn pub-type="epub">2576-2095</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39219374</article-id><article-id pub-id-type="pmc">PMC11680483</article-id>
<article-id pub-id-type="doi">10.1002/ame2.12477</article-id><article-id pub-id-type="publisher-id">AME212477</article-id><article-id pub-id-type="other">AMEM-2024-0019.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Regular Article</subject><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>An overview of different methods to establish a murine premature ovarian failure model</article-title><alt-title alt-title-type="left-running-head">Pouladvand et&#x000a0;al.</alt-title></title-group><contrib-group><contrib id="ame212477-cr-0001" contrib-type="author"><name><surname>Pouladvand</surname><given-names>Negar</given-names></name><xref rid="ame212477-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ame212477-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame212477-cr-0002" contrib-type="author"><name><surname>Azarnia</surname><given-names>Mahnaz</given-names></name><xref rid="ame212477-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame212477-cr-0003" contrib-type="author"><name><surname>Zeinali</surname><given-names>Hadis</given-names></name><xref rid="ame212477-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="ame212477-cr-0004" contrib-type="author"><name><surname>Fathi</surname><given-names>Rouhollah</given-names></name><xref rid="ame212477-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="ame212477-cr-0005" contrib-type="author" corresp="yes"><name><surname>Tavana</surname><given-names>Somayeh</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2066-6937</contrib-id><xref rid="ame212477-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>s.tavana@royan-rc.ac.ir</email></address></contrib></contrib-group><aff id="ame212477-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Embryology, Reproductive Biomedicine Research Center</named-content>
<institution>Royan Institute for Reproductive Biomedicine, ACECR</institution>
<city>Tehran</city>
<country country="IR">Iran</country>
</aff><aff id="ame212477-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Animal Biology, Faculty of Biological Sciences</named-content>
<institution>Kharazmi University</institution>
<city>Tehran</city>
<country country="IR">Iran</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>
Somayeh Tavana, Department of Embryology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.<break/>
Email: <email>s.tavana@royan-rc.ac.ir</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>7</volume><issue seq="100">6</issue><issue-id pub-id-type="doi">10.1002/ame2.v7.6</issue-id><issue-title>Themed Issue: Bone Regeneration and Disease Mechanisms</issue-title><fpage>835</fpage><lpage>852</lpage><history>
<date date-type="received"><day>19</day><month>1</month><year>2024</year></date>
<date date-type="accepted"><day>14</day><month>7</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2024 The Chinese Association for Laboratory Animal Sciences.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">Animal Models and Experimental Medicine</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:AME2-7-835.pdf"/><abstract><title>Abstract</title><p>Premature ovarian failure (POF)is defined as the loss of normal ovarian function before the age of 40 and is characterized by increased gonadotropin levels and decreased estradiol levels and ovarian reserve, often leading to infertility. The incomplete understanding of the pathogenesis of POF is a major impediment to the development of effective treatments for this disease, so the use of animal models is a promising option for investigating and identifying the molecular mechanisms involved in POF patients and developing therapeutic agents. As mice and rats are the most commonly used models in animal research, this review article considers studies that used murine POF models. In this review based on the most recent studies, first, we introduce 10 different methods for inducing murine POF models, then we demonstrate the advantages and disadvantages of each one, and finally, we suggest the most practical method for inducing a POF model in these animals. This may help researchers find the method of creating a POF model that is most appropriate for their type of study and suits the purpose of their research.</p></abstract><abstract abstract-type="graphical"><p>Ten different methods to induce murine POF models: (1) POF model induced by chemotherapy drugs, (2) radiotherapy&#x02010;induced POF model, (3) genetically induced POF model, (4) POF model induced by D&#x02010;galactose, (5) natural ovarian aging (NOA)&#x02010;induced POF model (6) physiological POF model with consecutive superovulation, (7) oophorectomy POF model, (8) POF model induced by 4&#x02010;vinylcyclohexene diepoxide (VCD), (9) autoimmunity induced POF model, (10) psychological stress POF model.<boxed-text position="anchor" content-type="graphic" id="ame212477-blkfxd-0001"><graphic xlink:href="AME2-7-835-g004.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="ame212477-kwd-0001">animal model</kwd><kwd id="ame212477-kwd-0002">chemotherapy drugs</kwd><kwd id="ame212477-kwd-0003">mouse</kwd><kwd id="ame212477-kwd-0004">ovarian damage</kwd><kwd id="ame212477-kwd-0005">ovarian reserve</kwd><kwd id="ame212477-kwd-0006">premature ovarian failure</kwd></kwd-group><counts><fig-count count="6"/><table-count count="2"/><page-count count="18"/><word-count count="14700"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>December 2024</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.1 mode:remove_FC converted:28.12.2024</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="AME212477-cit-2001">
<string-name>
<surname>Pouladvand</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Azarnia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zeinali</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Fathi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Tavana</surname>
<given-names>S</given-names>
</string-name>. <article-title>An overview of different methods to establish a murine premature ovarian failure model</article-title>. <source>Anim Models Exp Med</source>. <year>2024</year>;<volume>7</volume>:<fpage>835</fpage>&#x02010;<lpage>852</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ame2.12477</pub-id>
</mixed-citation>
</p></notes></front><body id="ame212477-body-0001"><sec id="ame212477-sec-0001"><label>1</label><title>INTRODUCTION</title><p>Premature ovarian failure (POF) is a common endocrine disease that causes female infertility. The patient goes through stages such as premature ovarian insufficiency (POI) and then, with further progression of the disease, eventually develops premature and complete ovarian failure or POF.<xref rid="ame212477-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> POF is characterized by high gonadotropin expression (follicle&#x02010;stimulating hormone (FSH)&#x02009;&#x02265;&#x02009;40&#x02009;IU/mL), low estradiol (E2) expression, follicular dysplasia, and amenorrhea for at least four months in women younger than 40&#x02009;years.<xref rid="ame212477-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="ame212477-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref> In addition, patients suffer from long&#x02010;term consequences of hypoestrogenism, including osteoporosis, cardiovascular diseases, and mental disorders such as depression.<xref rid="ame212477-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="ame212477-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> The causes of POF are unknown and are related to many complex factors such as genetic defects, autoimmune disorders, infection, iatrogenic factors (ovarian surgery, chemotherapy, or radiotherapy injury), etc.<xref rid="ame212477-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="ame212477-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> The phenotype of POF is significantly dependent on hormonal changes. Low levels of sex hormones (estrogens and inhibins) and increased levels of gonadotropins (luteinizing hormone (LH) and FSH) (hypergonadotropic amenorrhea) are well documented as causes of POF.<xref rid="ame212477-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="ame212477-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>
</p><p>As mentioned above, one of the causes of POF is iatrogenesis, which occurs during cancer chemotherapy and radiotherapy. Chemotherapy agents have become one of the important causes of premature ovarian failure in patients who present with cessation of ovarian function.<xref rid="ame212477-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> Chemotherapy drugs are divided into five groups: (1) alkylating agents with a high risk of infertility (such as cyclophosphamide, mechlorethamine, chlorambucil, procarbazine, busulfan and melphalan); (2) platinum&#x02010;based compounds with an average risk of infertility (such as cisplatin and carboplatin); (3) antimetabolites with a low risk of infertility (such as methotrexate, 5&#x02010;fluorouracil, and cytarabine); (4) vinca alkaloids with a low risk of infertility (such as vincristine and vinblastine); (5) anthracycline antibiotics with a low risk of infertility (such as daunorubicin, bleomycin, and doxorubicin (moderate risk of infertility)).<xref rid="ame212477-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="ame212477-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> Chemotherapy agents can cause double&#x02010;strand breaks (DSBs) in DNA. If a DBS is successfully repaired, the cell survives through loss of ataxia&#x02010;telangiectasia mutated (ATM) kinase. However, if repair pathways fail, DNA damage can lead to cell apoptosis and reduced ovarian reserve.<xref rid="ame212477-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Anticancer drugs cause DNA damage, inhibition of cell division, and finally lead to cell apoptosis. In the ovary, DNA damage, such as chemotherapy&#x02010;induced DNA double&#x02010;strand breaks, activates apoptosis of somatic granulosa cells and oocytes.<xref rid="ame212477-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>, <xref rid="ame212477-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>
</p><p>Despite the enormous impact of POF on the general health and quality of life of affected women, its pathophysiology is unclear. For this reason, animal models give us the opportunity to examine the pathogenesis comprehensively and hypothetically. Therefore, several attempts have been made to introduce an optimal model for POF.</p></sec><sec id="ame212477-sec-0002"><label>2</label><title>DIFFERENT METHODS OF CREATING POF ANIMAL MODELS</title><p>Currently, widely used animal models of POF can be classified as: (1) the POF model induced by chemotherapy drugs, (2) the radiotherapy&#x02010;induced POF model, (3) the genetically induced POF model, (4) the POF model induced by D&#x02010;galactose, (5) the natural ovarian aging&#x02010;induced POF model, (6) the physiological POF model with consecutive superovulation, (7) the oophorectomy POF model, (8) the POF model induced by 4&#x02010;vinylcyclohexene diepoxide, (9) the autoimmunity&#x02010;induced POF model, and (10) the psychological stress POF model, all of which are discussed in detail below.</p><sec id="ame212477-sec-0003"><label>2.1</label><title>POF model induced by chemotherapy drugs</title><sec id="ame212477-sec-0004"><label>2.1.1</label><title>Cyclophosphamide</title><p>Cyclophosphamide (CTX; chemical formula C<sub>7</sub>H<sub>15</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>2</sub>P&#x000b7;H<sub>2</sub>&#x000b7;H<sub>2</sub>O) is an effective alkylating anticancer agent widely used in cancer patients since 1950.<xref rid="ame212477-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="ame212477-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> CTX was the first chemotherapy drug associated with amenorrhea/POF and ovarian dysfunction (mouse and human)<xref rid="ame212477-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="ame212477-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> and is responsible for most cases of premature ovarian failure. It is also considered one of the most important gonadotoxic agents.<xref rid="ame212477-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> By accelerating the maturation process of ovarian follicles to mature follicles, CTX reduces ovarian reserves and eventually leads to premature ovarian failure in rats.<xref rid="ame212477-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> Recent studies have shown that cyclophosphamide decreases AMH, E2, estrogen, and progesterone and increases FSH and LH hormones.<xref rid="ame212477-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="ame212477-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="ame212477-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="ame212477-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="ame212477-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> There is also clear evidence that CTX leads to an up&#x02010;regulation of apoptosis in the ovary, as evidenced by rapid induction of DNA breaks<xref rid="ame212477-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> and altered expression levels of pro&#x02010;apoptotic and anti&#x02010;apoptotic genes.<xref rid="ame212477-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Another recent study has shown that the DNA damage&#x02010;induced p53 upregulated modulator of apoptosis (PUMA) protein plays a vital role in the induction of oocyte apoptosis in rodents following cyclophosphamide treatment and that cyclophosphamide&#x02010;induced follicular loss acts through a TAp63&#x02010;independent pathway,<xref rid="ame212477-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> while it has also been shown that the DNA damage and oocyte apoptosis induced by cyclophosphamide in the ovarian reserve involves the ATM&#x02010;CHK2&#x02010;TAp63 signaling pathway.<xref rid="ame212477-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> Other studies using a mouse animal model have confirmed the role of this pathway in the apoptosis of primordial follicle oocytes caused by cyclophosphamide.<xref rid="ame212477-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref>, <xref rid="ame212477-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> Recently, TAp63 (a specific isoform of P53, and a member of the P63 family) has been shown to be present in the oocyte nucleus and is a key regulator of the DNA damage or repair system in oocyte primordial follicles.<xref rid="ame212477-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref>, <xref rid="ame212477-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> ATM kinase is activated in response to DSBs.<xref rid="ame212477-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> Checkpoint kinase 2 (CHK2) is a protein component of the meiotic DNA damage checkpoint involved in DNA repair. It is a molecule downstream of ATM and subsequently transduces the signal to its downstream molecules, P53 and TAp63, and irreversibly activates the apoptotic pathway through modulator of apoptosis PUMA and phorbol&#x02010;12&#x02010;myristate&#x02010;13&#x02010;acetate (NOXA)&#x02010;induced proteins in the primordial follicles.<xref rid="ame212477-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> Finally, this pathway causes the depletion of the ovarian follicle reserves and POF<xref rid="ame212477-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="ame212477-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0001" ref-type="fig">1</xref>). Previous findings have also shown that apoptosis of granulosa cells in growing follicles occurs through the activation of the mitochondrial pathway and an increase in the expression of apoptotic proteins Bax, Caspase3, Caspase1 and a decrease in the expression of the anti&#x02010;apoptotic protein Bcl&#x02010;2 and Bclx&#x02010;l<xref rid="ame212477-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="ame212477-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref>, <xref rid="ame212477-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref>, <xref rid="ame212477-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>, <xref rid="ame212477-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2A</xref>). CTX has also been shown to cause a decrease in the number of primordial, primary, secondary, and antral follicles, as well as an increase in atretic follicles in the ovaries of mice and rats.<xref rid="ame212477-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="ame212477-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="ame212477-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="ame212477-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="ame212477-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref>, <xref rid="ame212477-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>, <xref rid="ame212477-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> The reduction of the follicular reserve caused by cyclophosphamide is related to overstimulation and reduction of the primordial follicle (PMF) reserve through activation of the PTEN/Akt/FOXO3 signaling pathway.<xref rid="ame212477-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="ame212477-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref>, <xref rid="ame212477-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> Increased phosphorylation of S473 AKT, S65 4E&#x02010;BP1 to P&#x02010;AKT, and P&#x02010;4E&#x02010;BP1 upon exposure to cyclophosphamide was shown by Goldman et&#x000a0;al.<xref rid="ame212477-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> In contrast, previous studies in a rodent model showed that inhibition of mTOR (mammalian target of rapamycin) prevented cyclophosphamide&#x02010;induced activation of PMFs through the PTEN/Akt/mTOR pathway<xref rid="ame212477-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref>, <xref rid="ame212477-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0003" ref-type="fig">3</xref>). Dysregulation of the Rictor/mTORC2/Akt/Foxo3a signaling axis can lead to cell apoptosis.<xref rid="ame212477-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> Exposure to cyclophosphamide causes follicular damage and POF induced by oxidative stress (OS).<xref rid="ame212477-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>, <xref rid="ame212477-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref> Cyclophosphamide increases the production of reactive oxygen species (ROS) and decreases enzymatic and non&#x02010;enzymatic antioxidants in mouse and rat ovarian tissue, which causes mitochondrial dysfunction, inflammation, lipid peroxidation, and apoptosis.<xref rid="ame212477-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="ame212477-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>, <xref rid="ame212477-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref>, <xref rid="ame212477-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref>, <xref rid="ame212477-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> Decreases in the levels of antioxidant enzymes such as superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT), and an increase in malondialdehyde (MDA) have been seen in premature ovarian failure caused by cyclophosphamide.<xref rid="ame212477-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="ame212477-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref>, <xref rid="ame212477-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>, <xref rid="ame212477-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>, <xref rid="ame212477-bib-0052" ref-type="bibr">
<sup>52</sup>
</xref>, <xref rid="ame212477-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref> In rats treated with CTX, the drug significantly increased the expression of Nrf2 (nuclear factor erythroid&#x02010;related factor 2), a key signaling transcription factor, and decreased the expression of the ovarian HO&#x02010;1 (hemooxygenase1) gene.<xref rid="ame212477-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> An essential sensor for oxidative stress is silent information regulator 1 (SIRT1), which coordinates cellular defense and repair mechanisms, controls the cell fate, and prevents the survival of damaged cells.<xref rid="ame212477-bib-0054" ref-type="bibr">
<sup>54</sup>
</xref> SIRT1 acts in both inflammation and oxidative stress by inhibiting nuclear factor kappa B (NF&#x02010;kB) signaling and stimulating the antioxidant response through the expression of the FOXO transcription factor. Cyclophosphamide increases SIRT1 in mouse oocytes as an adaptive response to oxidative stress.<xref rid="ame212477-bib-0053" ref-type="bibr">
<sup>53</sup>
</xref>, <xref rid="ame212477-bib-0055" ref-type="bibr">
<sup>55</sup>
</xref>, <xref rid="ame212477-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref>, <xref rid="ame212477-bib-0057" ref-type="bibr">
<sup>57</sup>
</xref> In rats treated with CTX, increased levels of NF&#x02010;kB, tumor necrosis factor &#x003b1; (TNF&#x02010;&#x003b1;), and cyclooxygenase 2 (COX&#x02010;2), and gene expression of inducible nitric oxide synthase (iNOS) and caspase 3 were observed<xref rid="ame212477-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> (Figures&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2B</xref> and <xref rid="ame212477-fig-0004" ref-type="fig">4</xref>).</p><fig position="float" fig-type="FIGURE" id="ame212477-fig-0001"><label>FIGURE 1</label><caption><p>The schematic diagram for gonadotoxic drugs and radiation&#x02010;induced primordial follicle death via the TAp63 signaling pathway. Gonadotoxic drugs and radiation treatment cause DNA damage in oocytes and induce a surveillance factor, CHK2, followed by activation of NOXA, and PUMA. Therefore, DNA&#x02010;damaged oocytes undergo apoptosis. ATM, Ataxia&#x02010;telangiectasia mutated; CHK2, Checkpoint kinase 2. Created with <ext-link xlink:href="http://biorender.com" ext-link-type="uri">BioRender.com</ext-link>.</p></caption><graphic xlink:href="AME2-7-835-g005" position="anchor" id="jats-graphic-3"/></fig><fig position="float" fig-type="FIGURE" id="ame212477-fig-0002"><label>FIGURE 2</label><caption><p>Two signaling pathways for apoptosis in premature ovarian failure via oxidative stress. (A) Activation of the mitochondrial apoptosis pathway. BAX (members of the pro&#x02010;apoptotic subgroup of the BCL&#x02010;2 family), which then assemble into large complexes that cause breaches in the mitochondrial outer membrane and the release of apoptogenic factors, such as cytochrome c. Cytochrome c, via binding to APAF1, causes the formation of the apoptosome. The initiator Caspase 9 becomes activated within this complex, which subsequently triggers the proteolytic activation of the effector Caspase 3. (B) Activation of SIRT1 pathway and inflammatory response via increased inflammatory factors. APAF1, Apoptotic peptidase activating factor 1; NF&#x02010;KB, Nuclear factor kappa B; NOXA, Phorbol&#x02010;12&#x02010;myristate&#x02010;13&#x02010;acetate; PUMA, P53 upregulated modulator of apoptosis; ROS, Reactive oxygen species; SIRT1, Silent information regulator 1. Created with <ext-link xlink:href="http://biorender.com" ext-link-type="uri">BioRender.com</ext-link>.</p></caption><graphic xlink:href="AME2-7-835-g001" position="anchor" id="jats-graphic-5"/></fig><fig position="float" fig-type="FIGURE" id="ame212477-fig-0003"><label>FIGURE 3</label><caption><p>The schematic diagram for regulation of primordial follicle activation via the PI3K signaling pathway. The accelerated activation of follicles via this pathway ultimately leads to the depletion of ovarian reserve. AKT, Protein kinase B; FOXO3, Forkhead Box O3; mTOR, Mammalian target of rapamycin; PI3K, Phosphoinositide 3&#x02010;kinase; PTEN, Phosphatase and tensin homolog deleted on chromosome 10. Created with <ext-link xlink:href="http://biorender.com" ext-link-type="uri">BioRender.com</ext-link>.</p></caption><graphic xlink:href="AME2-7-835-g002" position="anchor" id="jats-graphic-7"/></fig><fig position="float" fig-type="FIGURE" id="ame212477-fig-0004"><label>FIGURE 4</label><caption><p>Impact of cytotoxic agents on the ovary and the molecular pathways involved in a premature ovarian failure model in murine. CAT, Catalase; CID, Chemotherapy induced damage; COX&#x02010;2, Cyclooxygenase&#x02010;2; CX43, Connexin 43 protein; GPx, Glutathione peroxidase; GSH, Glutathione; iNOS, Inducible nitric oxide synthase; MDA, Malondialdehyde; SIRT1, Silent information regulator 1; SOD, Superoxide dismutase; TNF&#x02010;&#x003b1;, Tumor necrosis factor &#x003b1;. Created with <ext-link xlink:href="http://biorender.com" ext-link-type="uri">BioRender.com</ext-link>.</p></caption><graphic xlink:href="AME2-7-835-g003" position="anchor" id="jats-graphic-9"/></fig></sec><sec id="ame212477-sec-0005"><label>2.1.2</label><title>Cisplatin</title><p>Platinum&#x02010;based chemotherapy agents, including carboplatin, cisplatin, lobaplatin, nedaplatin, and oxaliplatin, account for approximately 50% of anticancer drugs used in the clinical setting.<xref rid="ame212477-bib-0058" ref-type="bibr">
<sup>58</sup>
</xref> The most common platinum&#x02010;based drug is cisplatin (CIS; chemical formula Cl<sub>2</sub>H<sub>6</sub>N<sub>2</sub>Pt).<xref rid="ame212477-bib-0059" ref-type="bibr">
<sup>59</sup>
</xref> The ability of CIS to inhibit cell division was first recognized in the 1960s<xref rid="ame212477-bib-0060" ref-type="bibr">
<sup>60</sup>
</xref> and it became the first platinum compound approved by the FDA for cancer treatment in 1987. Cisplatin is a heavy metal compound and acts as a DNA cross&#x02010;linking agent that interferes with DNA repair mechanisms, blocks cell division, causes DNA damage, and induces apoptotic cell death. CIS interacts with several different cellular components, but its primary biological target is DNA.<xref rid="ame212477-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Exposure of mouse and rat ovaries to CIS is associated with loss of ovarian reserve and increased follicular atresia.<xref rid="ame212477-bib-0061" ref-type="bibr">
<sup>61</sup>
</xref>, <xref rid="ame212477-bib-0062" ref-type="bibr">
<sup>62</sup>
</xref>, <xref rid="ame212477-bib-0063" ref-type="bibr">
<sup>63</sup>
</xref> Cisplatin&#x02010;induced DNA damage is proposed to lead to the activation of the apoptotic pathway through the activation of the apoptotic gene Bax and Caspase3 and inflammatory response<xref rid="ame212477-bib-0064" ref-type="bibr">
<sup>64</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2A,B</xref>). The tumor suppressor protein p53 and its family members, which play an important role in the extent of CIS&#x02010;induced DNA damage, are repaired and ultimately determine the cell's fate. ATR, a kinase involved in checkpoint activation, is activated by CIS and can, in turn, activate p53 as well as specific pathways of the MAPK cascade.<xref rid="ame212477-bib-0065" ref-type="bibr">
<sup>65</sup>
</xref> Both mouse and human primordial oocytes contain high concentrations of TAp63. Cisplatin activates TAp63&#x003b1; through the ATR/CHK1/CK1 pathway, and TAp63&#x003b1;, in turn, increases the expression of BH3&#x02010;only proapoptotic proteins PUMA and NOXA, which ultimately leads to oocyte apoptosis<xref rid="ame212477-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2</xref>). Studies show that the exposure of primordial follicles to CIS causes over&#x02010;activation of PMFs and reduced ovarian reserve and ultimately causes POF by activating the PTEN/Akt/FOXO3 pathway<xref rid="ame212477-bib-0067" ref-type="bibr">
<sup>67</sup>
</xref>, <xref rid="ame212477-bib-0068" ref-type="bibr">
<sup>68</sup>
</xref>, <xref rid="ame212477-bib-0069" ref-type="bibr">
<sup>69</sup>
</xref>, <xref rid="ame212477-bib-0070" ref-type="bibr">
<sup>70</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0003" ref-type="fig">3</xref>). Cisplatin significantly increases oxidative stress and decreases the level of SOD, GSH, and GPx antioxidants in rat ovarian tissue<xref rid="ame212477-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref>, <xref rid="ame212477-bib-0071" ref-type="bibr">
<sup>71</sup>
</xref>
</p></sec><sec id="ame212477-sec-0006"><label>2.1.3</label><title>Doxorubicin</title><p>Doxorubicin (DOX), with the chemical formula C<sub>27</sub>H<sub>29</sub>NO<sub>11</sub>, is an anthracycline antibiotic (14&#x02010;hydroxydaunomicyn), also known by the brand names Adriamycin or Rubex, which interferes with DNA and prevents its replication and transcription and is used to treat a wide range of cancers including breast, lung, lymphoma, gastric, ovarian, and leukemia. Recent evidence suggests that it is moderately gonadotoxic. The primary and best&#x02010;known mechanism of DOX is inhibition of the nuclear enzyme topoisomerase II.<xref rid="ame212477-bib-0072" ref-type="bibr">
<sup>72</sup>
</xref>, <xref rid="ame212477-bib-0073" ref-type="bibr">
<sup>73</sup>
</xref>, <xref rid="ame212477-bib-0074" ref-type="bibr">
<sup>74</sup>
</xref> DOX prevents the formation of the topoisomerase II&#x02010;DNA complex after the cleavage step by accumulating DNA fragments, which ultimately causes cell death. In addition, DOX stimulates the production of oxygen free radicals and other reactive oxygen species and also causes mitochondrial dysfunction.<xref rid="ame212477-bib-0075" ref-type="bibr">
<sup>75</sup>
</xref>, <xref rid="ame212477-bib-0076" ref-type="bibr">
<sup>76</sup>
</xref> Both free radical production and mitochondrial damage negatively affect cellular metabolism and membrane integrity, leading to severe side effects. DOX also enters DNA and disrupts DNA and RNA replication and protein synthesis.<xref rid="ame212477-bib-0077" ref-type="bibr">
<sup>77</sup>
</xref> Granulosa cells, stromal/theca cells isolated from developing mouse follicles, and oocytes undergo double&#x02010;stranded DNA breaks after DOX injection.<xref rid="ame212477-bib-0078" ref-type="bibr">
<sup>78</sup>
</xref>, <xref rid="ame212477-bib-0079" ref-type="bibr">
<sup>79</sup>
</xref> Apoptosis is the main and certainly the most studied process of DOX&#x02010;induced cell death in the ovary. Previous studies have shown that apoptosis and follicular deterioration occur 12&#x02009;h after DOX injection in mice.<xref rid="ame212477-bib-0080" ref-type="bibr">
<sup>80</sup>
</xref>, <xref rid="ame212477-bib-0081" ref-type="bibr">
<sup>81</sup>
</xref> Doxorubicin increases the induction of apoptosis of granulosa cells, increases ROS, and decreases the potential of the mitochondrial membrane. The downstream effectors in the apoptosis pathway, the death regulatory genes BAX, BCL&#x02010;2, and p53 are associated. When granulosa cells are exposed to DOX in&#x000a0;vitro, they show increased p53 mRNA expression<xref rid="ame212477-bib-0082" ref-type="bibr">
<sup>82</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2A</xref>). According to the results of these studies, doxorubicin activates mitochondrial apoptosis through Caspase12.<xref rid="ame212477-bib-0083" ref-type="bibr">
<sup>83</sup>
</xref> DOX can also cause DNA damage in relatively larger follicles, such as primary, secondary, and antral follicles, with many granulosa cells.<xref rid="ame212477-bib-0079" ref-type="bibr">
<sup>79</sup>
</xref> As mentioned above, Tap63 is activated after oocyte DNA damage, and DOX affects Tap63, providing a pathway for the loss of PMFs<xref rid="ame212477-bib-0066" ref-type="bibr">
<sup>66</sup>
</xref> (Figures&#x000a0;<xref rid="ame212477-fig-0001" ref-type="fig">1</xref> and <xref rid="ame212477-fig-0004" ref-type="fig">4</xref>).</p></sec><sec id="ame212477-sec-0007"><label>2.1.4</label><title>Busulfan</title><p>Busulfan (BU) is a drug combined with cyclophosphamide for managing and treating allogeneic hematopoietic progenitor cell transplantation, especially for patients with chronic myelogenous leukemia. This drug, which belongs to the group of anticancer drugs and is defined as an alkylating agent, has been used since the 1950s. By binding to cysteine molecules of histone proteins, busulfan leads to DNA binding to proteins. Busulfan also disrupts the cellular redox balance by interacting with the sulfhydryl groups of glutathione, thereby increasing oxidative stress in cancer cells.<xref rid="ame212477-bib-0084" ref-type="bibr">
<sup>84</sup>
</xref> The classical chemotherapy drugs cyclophosphamide and busulfan (CTX/BU), often used to treat cancer in the clinic, have severe reproductive toxicity and have been used to induce POF in an animal model.<xref rid="ame212477-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref>
</p><p>The combination of busulfan and cyclophosphamide decreases the size of ovaries, decreases the number of follicles,<xref rid="ame212477-bib-0086" ref-type="bibr">
<sup>86</sup>
</xref> and increases the number of atretic follicles in mice. On the other hand, busulfan and cyclophosphamide cause apoptosis by increasing the pro&#x02010;inflammatory cytokines IL&#x02010;6 and IL&#x02010;8, reducing the antioxidant factors superoxide dismutase and Nrf2, as well as reducing the anti&#x02010;apoptotic protein Bcl&#x02010;2 and increasing the apoptotic protein Bax<xref rid="ame212477-bib-0085" ref-type="bibr">
<sup>85</sup>
</xref>, <xref rid="ame212477-bib-0087" ref-type="bibr">
<sup>87</sup>
</xref>, <xref rid="ame212477-bib-0088" ref-type="bibr">
<sup>88</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0001" ref-type="fig">1A,B</xref>). In this study, it has been shown that the weights of the ovaries and the uterus, as well as the body weight, were significantly reduced under treatment with cyclophosphamide and busulfan.<xref rid="ame212477-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref>, <xref rid="ame212477-bib-0090" ref-type="bibr">
<sup>90</sup>
</xref> Liu et&#x000a0;al. showed that in mice treated with CTX and BU, increased expression of AKT and PI3K phosphorylation occurs<xref rid="ame212477-bib-0087" ref-type="bibr">
<sup>87</sup>
</xref> (Figures&#x000a0;<xref rid="ame212477-fig-0003" ref-type="fig">3</xref> and <xref rid="ame212477-fig-0004" ref-type="fig">4</xref>).</p></sec></sec><sec id="ame212477-sec-0008"><label>2.2</label><title>Radiotherapy&#x02010;induced POF model</title><p>Radiotherapy is one of the standard cytotoxic therapies for cancer. However, it has a profound effect on ovarian function, leading to premature ovarian failure and infertility.<xref rid="ame212477-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref> Radiation to the brain can damage the pituitary gland and lead to the deregulation of gonadotropin hormones, which are needed to maintain normal ovarian function.<xref rid="ame212477-bib-0092" ref-type="bibr">
<sup>92</sup>
</xref> In addition, radiation directly destroys ovarian follicles, leading to depletion of the primordial pool,<xref rid="ame212477-bib-0093" ref-type="bibr">
<sup>93</sup>
</xref> thereby predisposing women to premature menopause and infertility,<xref rid="ame212477-bib-0094" ref-type="bibr">
<sup>94</sup>
</xref> during or shortly after completion of irradiation.<xref rid="ame212477-bib-0091" ref-type="bibr">
<sup>91</sup>
</xref> Many molecular mechanisms are involved in the pathogenesis of radiation&#x02010;induced toxicity, and one of these critical mechanisms is the inflammatory cascade.<xref rid="ame212477-bib-0095" ref-type="bibr">
<sup>95</sup>
</xref> Ionizing radiation reaching cancerous tissue produces toxic free radicals and reactive oxygen species that attack critical macromolecules such as DNA, disrupt mitochondrial membrane integrity, and activate the inflammatory and apoptotic pathways, leading to follicular death<xref rid="ame212477-bib-0096" ref-type="bibr">
<sup>96</sup>
</xref>, <xref rid="ame212477-bib-0097" ref-type="bibr">
<sup>97</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2A,B</xref>). Several studies have shown that DSBs induced by radiation induce apoptosis and follicle pool depletion through activation of the ATM/CHK2/Tap63 pathway<xref rid="ame212477-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref>, <xref rid="ame212477-bib-0098" ref-type="bibr">
<sup>98</sup>
</xref>, <xref rid="ame212477-bib-0099" ref-type="bibr">
<sup>99</sup>
</xref>, <xref rid="ame212477-bib-0100" ref-type="bibr">
<sup>100</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2</xref>).</p><p>The estimated dose at which half of the follicles are destroyed in humans (LD<sub>50</sub>) is 4&#x02009;Gy.<xref rid="ame212477-bib-0101" ref-type="bibr">
<sup>101</sup>
</xref> In another study, a significant decrease in antral follicle count (AFC) and the weight of the ovaries of rats and a decrease in the serum levels of AMH and E2 were observed 2&#x02009;days after irradiation. On the other hand, oxidative stress caused by gamma radiation increased in rat ovaries and caused a significant decrease in antioxidant activities.<xref rid="ame212477-bib-0102" ref-type="bibr">
<sup>102</sup>
</xref> Ovarian damage caused by irradiation causes an increase in inflammation by increasing the inflammatory factors NF&#x02010;kB, TNF &#x003b1;, iNOS, and COX&#x02010;2 and increasing apoptosis by increasing the expression of cytochrome c and caspase 3.<xref rid="ame212477-bib-0103" ref-type="bibr">
<sup>103</sup>
</xref> Exposure to &#x003d2; radiation decreases FOXO1 and FOXO3 expression, which could reflect early activation of primordial follicles followed by secondary follicular atresia. In addition, a significant increase in apoptotic factors such as Bax and Bax/Bcl2 ratio and caspase&#x02010;3 expression was observed in rats exposed to radiation (Figures&#x000a0;<xref rid="ame212477-fig-0001" ref-type="fig">1</xref> and <xref rid="ame212477-fig-0004" ref-type="fig">4</xref>).</p></sec><sec id="ame212477-sec-0009"><label>2.3</label><title>Genetically induced POF model</title><p>Genetic analyses of POF patients have identified several chromosomal abnormalities, single gene mutations, and genetic polymorphisms from different biological pathways associated with the development of POF. However, the genetic defects investigated so far have been shown to contribute only a small percentage to the development of POF. The diverse etiology of POF is consistent with these findings and suggests that the pathogenesis of non&#x02010;syndromic POF is unlikely to be caused by a single gene or genetic defect, but rather that POF is a heterogeneous genetic disease involving the interaction of multiple genetic defects and environmental factors.<xref rid="ame212477-bib-0104" ref-type="bibr">
<sup>104</sup>
</xref> Abnormalities of the X chromosome have long been recognized as the most common genetic cause of POF, accounting for about 12% of cases. These abnormalities usually include complete or partial X chromosome deletions, duplications, or translocations.<xref rid="ame212477-bib-0105" ref-type="bibr">
<sup>105</sup>
</xref>, <xref rid="ame212477-bib-0106" ref-type="bibr">
<sup>106</sup>
</xref> Important genes associated with POF and identified on the long arm of the X chromosome include the fragile x mental retardation 1 (FMR1) gene, which is associated with fragile X syndrome<xref rid="ame212477-bib-0107" ref-type="bibr">
<sup>107</sup>
</xref> Apart from chromosomal abnormalities, single gene changes can also cause POI.<xref rid="ame212477-bib-0108" ref-type="bibr">
<sup>108</sup>
</xref>
</p><sec id="ame212477-sec-0010"><label>2.3.1</label><title>Genes related to meiosis and DNA replication and repair</title><p>If an error occurs during meiosis, DNA replication, or DNA repair, the genetic information is negatively affected and leads to apoptosis of germ cells and infertility. Therefore, investigating the genes involved in these processes is useful for a better understanding of POF. Recent studies have shown that SPO11 (sporulation protein), DMC1 (disrupted meiotic cDNA 1 homolog), MSH4 (mutS homolog 4), and MSH5 (mutS homolog 5) are important for the formation of this disease.<xref rid="ame212477-bib-0108" ref-type="bibr">
<sup>108</sup>
</xref>, <xref rid="ame212477-bib-0109" ref-type="bibr">
<sup>109</sup>
</xref>, <xref rid="ame212477-bib-0110" ref-type="bibr">
<sup>110</sup>
</xref> Meiotic events play an essential role in the formation of follicles, and mouse models caused by mutations in meiosis&#x02010;related genes show defects in oocyte development. SPO11 is an essential enzyme for creating DSBs during meiosis.<xref rid="ame212477-bib-0111" ref-type="bibr">
<sup>111</sup>
</xref> Spo11<sup>&#x02212;/&#x02212;</sup> mice have a decreased number of primordial follicles at the time of follicle formation, leading to complete infertility in adults due to the lack of mature follicles.<xref rid="ame212477-bib-0112" ref-type="bibr">
<sup>112</sup>
</xref> Msh4<sup>&#x02212;/&#x02212;</sup> and Msh5<sup>&#x02212;/&#x02212;</sup> mice are sterile and lack oocytes due to defects in meiosis and severe gametogenic failure.<xref rid="ame212477-bib-0113" ref-type="bibr">
<sup>113</sup>
</xref>
</p></sec><sec id="ame212477-sec-0011"><label>2.3.2</label><title>Genes related to the survival, growth, and activation of primordial follicles</title><p>FIGLA (Factor in the germline, alpha), NOBOX (Newborn ovary homeobox&#x02010;encoding gene) and FOXL2 (Forkhead box L2) genes are important for the transition of primordial follicles to primary follicles. FOXL2 is mainly expressed in granulosa cells in ovaries from embryogenesis to adult life.<xref rid="ame212477-bib-0114" ref-type="bibr">
<sup>114</sup>
</xref> In Foxl2<sup>&#x02212;/&#x02212;</sup> ovaries, granulosa cell differentiation is blocked and thus the transition from primordial follicles to primary follicles is blocked. Mice are infertile due to impaired follicular development.<xref rid="ame212477-bib-0115" ref-type="bibr">
<sup>115</sup>
</xref> Mutations in the FOXL2 gene cause blepharophimosis/ptosis/epicanthus inversus syndrome (BPES) type I associated with POF.<xref rid="ame212477-bib-0114" ref-type="bibr">
<sup>114</sup>
</xref>, <xref rid="ame212477-bib-0115" ref-type="bibr">
<sup>115</sup>
</xref> The NOBOX gene, an oocyte&#x02010;specific homeobox gene, is essential for follicle development after birth. In mice lacking the NOBOX gene, accelerated oocyte loss occurs after birth and impaired transition of primordial follicles to developing follicles.<xref rid="ame212477-bib-0116" ref-type="bibr">
<sup>116</sup>
</xref> FIGLA is expressed in female germ cells and plays an important role in oogenesis. In FIGLA&#x02010;deficient mice, although embryonic gonadogenesis appears normal, primordial follicles fail to form at birth, and a severe reduction in oocytes results in shrunken ovaries and sterility in female mice.<xref rid="ame212477-bib-0117" ref-type="bibr">
<sup>117</sup>
</xref> Estrogen deficiency causes significant metabolic changes in mice due to loss of FSH&#x02010;R signaling and subsequent cessation of reproductive function. The FSHR<sup>&#x02212;/&#x02212;</sup> mouse phenotype is a suitable model for studying ovarian failure in humans [13]. In one study, FSH&#x02010;R knockout mutations (FORKO) in mice caused disturbances in the estrous cycle, ovulation, and uterine atrophy, as well as ovarian dysfunction and decreased estrogen.<xref rid="ame212477-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref>, <xref rid="ame212477-bib-0119" ref-type="bibr">
<sup>119</sup>
</xref> In another study of adult female FORKO mice, ovaries were 45% smaller and increased levels of testosterone and LH hormones were observed.<xref rid="ame212477-bib-0118" ref-type="bibr">
<sup>118</sup>
</xref>
</p></sec><sec id="ame212477-sec-0012"><label>2.3.3</label><title>Genes related to the development of primordial germ cells (PGCs)</title><p>Defects in the development of PGCs lead to the lack of functional eggs and follicles and as a result POF.<xref rid="ame212477-bib-0109" ref-type="bibr">
<sup>109</sup>
</xref> BMPs, members of the TGF family of growth factors, are important for the migration and development of PGCs. BMP4<sup>&#x02212;/&#x02212;</sup> embryos lack PGCs.<xref rid="ame212477-bib-0120" ref-type="bibr">
<sup>120</sup>
</xref> Also, the number of PGCs is significantly reduced in BMP8b<sup>&#x02212;/&#x02212;</sup> and BMP2<sup>&#x02212;/&#x02212;</sup> mice, which leads to the reduction or loss of primordial follicles.<xref rid="ame212477-bib-0121" ref-type="bibr">
<sup>121</sup>
</xref> DAZL (Deleted in azoospermia&#x02010;like) gene is necessary for the growth of germ cells.<xref rid="ame212477-bib-0122" ref-type="bibr">
<sup>122</sup>
</xref> Disruption of the DAZL gene leads to a decrease in the number of germ cells in mouse embryos and the complete absence of ovarian follicles in mature mouse ovaries.<xref rid="ame212477-bib-0123" ref-type="bibr">
<sup>123</sup>
</xref> Nanos C2HC&#x02010;Type Zinc Finger 3 (NANOS3) gene is known to be required for PGC development, migration, and maintenance. Female mice lacking the NANOS3 gene are infertile because they don't have any PGCs in the gonad by embryonic day 12.5 (E12.5).<xref rid="ame212477-bib-0124" ref-type="bibr">
<sup>124</sup>
</xref>
</p></sec><sec id="ame212477-sec-0013"><label>2.3.4</label><title>Genes related to RNA metabolism and translation</title><p>Defects in mitochondrial function and non&#x02010;coding (small) RNAs, ncRNAs, and long ncRNAs are useful for doctors to diagnose idiopathic POI cases and predict the risk of POI in women.<xref rid="ame212477-bib-0108" ref-type="bibr">
<sup>108</sup>
</xref> Eukaryotic translation initiation factor 4E nuclear import factor 1 (EIF4ENIF1) is an RNA&#x02010;binding protein and is a component of the cytoplasmic ribonucleoprotein complex such as the mitochondrial&#x02010;associated ribonucleoprotein domain (MARDO).<xref rid="ame212477-bib-0125" ref-type="bibr">
<sup>125</sup>
</xref> EIF4ENIF1 is one of the genes known to cause POF and plays an essential role in inhibiting mRNA translation and regulating mRNA instability in ovarian cells.<xref rid="ame212477-bib-0126" ref-type="bibr">
<sup>126</sup>
</xref> In one study, it was shown that haploinsufficiency of EIF4ENIF1 protein causes reproductive damage in mice and impairs oocyte maturation.<xref rid="ame212477-bib-0127" ref-type="bibr">
<sup>127</sup>
</xref>
</p><p>POF is a complex disorder that may have several different genetic causes.<xref rid="ame212477-bib-0109" ref-type="bibr">
<sup>109</sup>
</xref> The genetic model is a complex model in which the phenotype of complete gene deletion in knockout models may not be mimicked by single gene mutations.<xref rid="ame212477-bib-0128" ref-type="bibr">
<sup>128</sup>
</xref> The disadvantage of this POF animal model is the high cost.<xref rid="ame212477-bib-0129" ref-type="bibr">
<sup>129</sup>
</xref> The genes associated with POF are classified according to the biological processes they participate in (Table&#x000a0;<xref rid="ame212477-tbl-0001" ref-type="table">1</xref>).</p><table-wrap position="float" id="ame212477-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>List of candidate genes associated with non&#x02010;syndromic premature ovarian failure.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Classification</th><th align="left" valign="bottom" rowspan="1" colspan="1">Gene</th><th align="left" valign="bottom" rowspan="1" colspan="1">Mechanism of action</th><th align="left" valign="bottom" rowspan="1" colspan="1">Reference</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="3" valign="top" colspan="1">Meiosis and DNA replication and repair</td><td align="left" valign="top" rowspan="1" colspan="1">SPO11</td><td align="left" valign="top" rowspan="1" colspan="1">Creating DSBs during meiosis</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0111" ref-type="bibr">111</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MSH4</td><td align="left" valign="top" rowspan="1" colspan="1">Synapsis and DNA repair</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0130" ref-type="bibr">130</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MSH5</td><td align="left" valign="top" rowspan="1" colspan="1">Synapsis and DNA repair</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0130" ref-type="bibr">130</xref>]</td></tr><tr><td align="left" rowspan="4" valign="top" colspan="1">Survival, growth and activation of primordial follicles</td><td align="left" valign="top" rowspan="1" colspan="1">FIGLA</td><td align="left" valign="top" rowspan="1" colspan="1">Oogenesis and development of secondary follicles</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0131" ref-type="bibr">131</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NOBOX</td><td align="left" valign="top" rowspan="1" colspan="1">Folliculogenesis and steroidogenesis</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0116" ref-type="bibr">116</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FOXL2</td><td align="left" valign="top" rowspan="1" colspan="1">Growth and development of follicles</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0115" ref-type="bibr">115</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FSHR</td><td align="left" valign="top" rowspan="1" colspan="1">Follicular development and ovarian hormone regulation</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0132" ref-type="bibr">132</xref>]</td></tr><tr><td align="left" rowspan="3" valign="top" colspan="1">Development of PGCs</td><td align="left" valign="top" rowspan="1" colspan="1">BMPs</td><td align="left" valign="top" rowspan="1" colspan="1">Generation of primordial germ cells</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0120" ref-type="bibr">120</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DAZL</td><td align="left" valign="top" rowspan="1" colspan="1">Growth of germ cells</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0122" ref-type="bibr">122</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NANOS3</td><td align="left" valign="top" rowspan="1" colspan="1">Migration, development, and maintenance of PGCs</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0124" ref-type="bibr">124</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RNA metabolism and translation</td><td align="left" valign="top" rowspan="1" colspan="1">EIF4ENIF1</td><td align="left" valign="top" rowspan="1" colspan="1">Translation repression</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0127" ref-type="bibr">127</xref>]</td></tr></tbody></table></table-wrap></sec></sec><sec id="ame212477-sec-0015"><label>2.4</label><title>POF model induced by D&#x02010;galactose (D&#x02010;gal)</title><p>Galactosemia &#x02013; a rare genetic metabolic disorder that affects a person's ability to metabolize the sugar galactose &#x02013; is associated with POF. Accumulated galactose (GAL) in the absence of galactose&#x02010;1&#x02010;phosphate uridyltransferase (GALT) has an ototoxic effect in galactosemic women, ultimately leading to accelerated decline in the ovarian follicle reserve and occurrence of POF.<xref rid="ame212477-bib-0133" ref-type="bibr">
<sup>133</sup>
</xref>, <xref rid="ame212477-bib-0134" ref-type="bibr">
<sup>134</sup>
</xref> The ovotoxicity characteristic of galactose has led to using this monosaccharide to induce POF modeling. According to the results of these studies, D&#x02010;galactose significantly increases the expression of &#x003b3;H2AX and BP153, two markers of DNA damage.<xref rid="ame212477-bib-0135" ref-type="bibr">
<sup>135</sup>
</xref> Also, an increase in the level of FSH and LH hormones and a decrease in the level of E2, AMH, and progesterone hormones have been observed in rats treated with D&#x02010;galactose.<xref rid="ame212477-bib-0135" ref-type="bibr">
<sup>135</sup>
</xref>, <xref rid="ame212477-bib-0136" ref-type="bibr">
<sup>136</sup>
</xref>, <xref rid="ame212477-bib-0137" ref-type="bibr">
<sup>137</sup>
</xref>, <xref rid="ame212477-bib-0138" ref-type="bibr">
<sup>138</sup>
</xref> The results of a study in rats show that the ovarian dysfunction in galactosemia may be due to the higher level of expression of cell death inducers (Fas/FasL) and decreased expression of survival signals (Riap and Xiap) in developing follicles, resulting in apoptosis.<xref rid="ame212477-bib-0139" ref-type="bibr">
<sup>139</sup>
</xref> Treatment with D&#x02010;gal reduced the ratio of primordial follicles, primary follicles, and antral follicles and increased the ratio of atretic follicles,<xref rid="ame212477-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref>, <xref rid="ame212477-bib-0135" ref-type="bibr">
<sup>135</sup>
</xref>, <xref rid="ame212477-bib-0136" ref-type="bibr">
<sup>136</sup>
</xref> while, on the other hand, it decreased the activity of antioxidant enzymes SOD, GSH, and decreased Nrf2 expression. The downstream antioxidant enzymes in treated mice are GCLC, HO&#x02010;1, and NQO1.<xref rid="ame212477-bib-0056" ref-type="bibr">
<sup>56</sup>
</xref>, <xref rid="ame212477-bib-0136" ref-type="bibr">
<sup>136</sup>
</xref>, <xref rid="ame212477-bib-0137" ref-type="bibr">
<sup>137</sup>
</xref> Decreased levels of SOD, GSH&#x02010;px, and increased levels of MDA,<xref rid="ame212477-bib-0137" ref-type="bibr">
<sup>137</sup>
</xref>, <xref rid="ame212477-bib-0138" ref-type="bibr">
<sup>138</sup>
</xref> mRNA Sod2, and mRNA CAT, as well as increased levels of Bax, Caspase 3, Caspase 9, and decreased levels of Bcl&#x02010;2, p&#x02010;AKt, p&#x02010;PI3K in mice treated with D&#x02010;gal have been observed<xref rid="ame212477-bib-0136" ref-type="bibr">
<sup>136</sup>
</xref>, <xref rid="ame212477-bib-0137" ref-type="bibr">
<sup>137</sup>
</xref>, <xref rid="ame212477-bib-0138" ref-type="bibr">
<sup>138</sup>
</xref> (Figures&#x000a0;<xref rid="ame212477-fig-0001" ref-type="fig">1A</xref> and <xref rid="ame212477-fig-0003" ref-type="fig">3</xref>). In a study by Lee et&#x000a0;al., an increase in the level of inflammatory cytokines such as IL&#x02010;6, TNF&#x02010;&#x003b1;, and IL&#x02010;1&#x003b2; was observed in the ovaries of rats treated with D&#x02010;gal<xref rid="ame212477-bib-0138" ref-type="bibr">
<sup>138</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2B</xref>). Although the GAL animal model can simulate the physiological aging characteristics of clinical POF patients, this model has a lower success rate and a longer cycle<xref rid="ame212477-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0004" ref-type="fig">4</xref>).</p></sec><sec id="ame212477-sec-0016"><label>2.5</label><title>Natural ovarian aging&#x02010;induced POF model</title><p>For humans, especially those who have passed their 40s, the process of ovarian follicle decline can be accelerated by many factors such as aging.<xref rid="ame212477-bib-0141" ref-type="bibr">
<sup>141</sup>
</xref> After birth, the quality and quantity of oocytes in the ovarian cortex follicles gradually decrease during normal ovarian aging (NOA).<xref rid="ame212477-bib-0142" ref-type="bibr">
<sup>142</sup>
</xref> In addition, with the aging of ovaries, inflammatory cytokines (TNF&#x02010;&#x003b1;, IL&#x02010;6) and oxidant factors increase, so oxidative stress and inflammation play a role in the pathogenesis of POF<xref rid="ame212477-bib-0143" ref-type="bibr">
<sup>143</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2B</xref>). In several studies, female rats (12&#x02013;15&#x02009;months old) were used for the natural ovarian aging&#x02010;induced POF model (NOA&#x02010;POF). A decrease in the level of estradiol hormone, AMH, an increase in the level of FSH hormone, and an increase in oxidative stress and apoptosis were observed in NOA mice.<xref rid="ame212477-bib-0144" ref-type="bibr">
<sup>144</sup>
</xref>, <xref rid="ame212477-bib-0145" ref-type="bibr">
<sup>145</sup>
</xref>, <xref rid="ame212477-bib-0146" ref-type="bibr">
<sup>146</sup>
</xref> One of the natural ovarian aging&#x02010;induced POF model's disadvantages is that it requires a considerable amount of time. On the other hand, there are also some advantages including low cost, and not having any side effects since no drugs are injected (Figure&#x000a0;<xref rid="ame212477-fig-0004" ref-type="fig">4</xref>).</p></sec><sec id="ame212477-sec-0017"><label>2.6</label><title>Physiological POF model with consecutive superovulation</title><p>Induction of POF in mice using 5 to 15 consecutive superovulation treatments with a continuous intraperitoneal injection of pregnant mare serum (PMSG), human chorionic gonadotropin (HCG), and prostaglandin F2&#x003b1; (PGF2&#x003b1;) resulted in a stable physiological model. According to studies by Xiaowei Nie et&#x000a0;al., the sequential treatment of superovulation causes a significant increase in the level of FSH and LH hormones, the oxidative stress indicator MDA, and the number of antral and atretic follicles, as well as a significant decrease in the level of E2, P and Inhibin B hormones. SOD, GSH&#x02010;Px enzymes, and the number of primordial, primary and secondary follicles. Increased apoptosis of mouse ovarian granulosa cells through the SIRT1/FOXO1 signaling pathway was observed in the five consecutive superovulation treatment groups<xref rid="ame212477-bib-0147" ref-type="bibr">
<sup>147</sup>
</xref> (Figures&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2B</xref> and <xref rid="ame212477-fig-0004" ref-type="fig">4</xref>).</p></sec><sec id="ame212477-sec-0018"><label>2.7</label><title>Oophorectomy POF model</title><p>Oophorectomy is the surgical removal of one or both ovaries. It may be done for ovarian pathology (such as neoplasm), risk reduction purposes (reducing the risk of reoperation or cancer), or fertility preservation.<xref rid="ame212477-bib-0148" ref-type="bibr">
<sup>148</sup>
</xref>, <xref rid="ame212477-bib-0149" ref-type="bibr">
<sup>149</sup>
</xref>, <xref rid="ame212477-bib-0150" ref-type="bibr">
<sup>150</sup>
</xref> Bilateral oophorectomy causes infertility and menopause in patients with physiological changes.<xref rid="ame212477-bib-0151" ref-type="bibr">
<sup>151</sup>
</xref> In one study, an oophorectomy was created in a rat by removing one of the ovaries (ovariectomized). As a result of this study, the serum levels of AMH and E2 hormones decreased significantly in the oophorectomy rat model. Also, this model's total number of primordial follicles decreased, and ROS levels increased compared to the control group<xref rid="ame212477-bib-0152" ref-type="bibr">
<sup>152</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0004" ref-type="fig">4</xref>). Ovariectomy has been a valuable tool for understanding estrogen deficiency through animal experiments. The disadvantage of oophorectomy model is that it cannot mimic spontaneous POF because the transitional period of ovarian emptying is neglected.<xref rid="ame212477-bib-0133" ref-type="bibr">
<sup>133</sup>
</xref>
</p></sec><sec id="ame212477-sec-0019"><label>2.8</label><title>POF model induced by 4&#x02010;vinylcyclohexene diepoxide</title><p>4&#x02010;Vinylcyclohexene diepoxide (VCD) is a metabolite of 4&#x02010;vinylcyclohexene (VCH), which is often used in the industrial context and is classified as a carcinogen according to the classification of the International Agency for Research on Cancer (IARC). VCD, a chemical intermediate, is a reactive diluent for epoxy resins and diepoxides. In the studies conducted by the National Toxicology Program (NTP) on the carcinogenic potential of VCD, it was reported that in addition to carcinogenic effects, it also has ovotoxic effects.<xref rid="ame212477-bib-0153" ref-type="bibr">
<sup>153</sup>
</xref> Exposure to commercial or environmental toxins can cause serious fertility problems in women. Today, one of the biggest causes of infertility is the increasing exposure to these toxic agents. The toxic effect of VCD can induce premature ovarian failure by reducing the primordial follicle reserve in the ovaries.<xref rid="ame212477-bib-0154" ref-type="bibr">
<sup>154</sup>
</xref> In&#x000a0;vivo and in&#x000a0;vitro experiments have shown that VCD can cause oocyte dysfunction and toxic effects in the ovary.<xref rid="ame212477-bib-0155" ref-type="bibr">
<sup>155</sup>
</xref>, <xref rid="ame212477-bib-0156" ref-type="bibr">
<sup>156</sup>
</xref> According to the results of previous studies, Bax, Caspase2, and Caspase3, but not acid sphingomyelinase (ASMase) or aromatic hydrocarbon receptor (Ahr), are functionally important in VCD&#x02010;induced follicle loss.<xref rid="ame212477-bib-0156" ref-type="bibr">
<sup>156</sup>
</xref> Also, in this study, VCD caused a decrease in all types of follicles, especially primordial and primary follicles, as well as a decrease in AMH hormone expression in rat ovaries.<xref rid="ame212477-bib-0153" ref-type="bibr">
<sup>153</sup>
</xref> Gap junction connexin 43 protein (Cx43) is an inversely related protein in apoptosis and plays a vital role in the survival of granulosa cells.<xref rid="ame212477-bib-0157" ref-type="bibr">
<sup>157</sup>
</xref> In this study,<xref rid="ame212477-bib-0153" ref-type="bibr">
<sup>153</sup>
</xref> by increasing the expression of Caspase 3 and iNOS, the increase in oxidative stress caused by exposure to VCD caused a decrease in the expression of Cx43 protein (which plays an important role in the survival of granulosa cells and has an inverse relationship with the apoptosis index) and an increase in apoptosis (Figures&#x000a0;<xref rid="ame212477-fig-0002" ref-type="fig">2A,B</xref> and <xref rid="ame212477-fig-0004" ref-type="fig">4</xref>).</p></sec><sec id="ame212477-sec-0020"><label>2.9</label><title>Autoimmune&#x02010;induced premature ovarian failure</title><p>Although the exact causes of POF remain unknown, autoimmune mechanisms may be involved in approximately 10&#x02013;30% of women with POF,<xref rid="ame212477-bib-0158" ref-type="bibr">
<sup>158</sup>
</xref>, <xref rid="ame212477-bib-0159" ref-type="bibr">
<sup>159</sup>
</xref> which may be a simple autoimmune disease of the ovary or associated with other immune disorders. The immune pathology of autoimmune ovarian disease (AOD) is mainly associated with non&#x02010;infectious ovarian inflammation (oophoritis), ovarian atrophy, and serum autoantibodies to ovarian antigens.<xref rid="ame212477-bib-0160" ref-type="bibr">
<sup>160</sup>
</xref> Ovarian dysfunction caused by an autoimmune mechanism may be related to zona pellucida (ZP) antigens such as ZP3 glycoprotein.<xref rid="ame212477-bib-0161" ref-type="bibr">
<sup>161</sup>
</xref> ZP3 is the main receptor in the zona pellucida that binds to sperm during fertilization.<xref rid="ame212477-bib-0162" ref-type="bibr">
<sup>162</sup>
</xref> In one study, an animal model of POF in mice was created by injecting glycoprotein ZP3 to cause autoimmune damage to the ovary.<xref rid="ame212477-bib-0158" ref-type="bibr">
<sup>158</sup>
</xref> Immunization of animals with ZP3 glycoprotein by activating T cells and anti&#x02010;ZP3 antibodies (AZPAbs) interferes with normal follicular development and leads to follicular emptying and amenorrhea.<xref rid="ame212477-bib-0158" ref-type="bibr">
<sup>158</sup>
</xref>, <xref rid="ame212477-bib-0163" ref-type="bibr">
<sup>163</sup>
</xref> Evaluation of AZPAb expression, examination of ovarian histopathology, and a significant increase of FSH hormone and a decrease of E2 hormone show that the POF model was successfully established through this approach<xref rid="ame212477-bib-0158" ref-type="bibr">
<sup>158</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0004" ref-type="fig">4</xref>). In another study, POF was induced in rats by causing autoimmune ovarian inflammation by subcutaneous injection of 0.35&#x02009;mL of ovarian antigen 3 times, once every 10&#x02009;days. Rat ovarian tissue supernatant protein with Freund's adjuvant acts as ovarian antigen. Decreased levels of E2, P4, and AMH hormones and irregular estrous cycles were shown 2&#x02009;weeks after ovarian antigen injection in rats.<xref rid="ame212477-bib-0164" ref-type="bibr">
<sup>164</sup>
</xref> Because this method is rarely used, it is unclear what concentration of ovarian antigen can be used to successfully construct an autoimmune POF model. On the other hand, although autoantibodies are generated in most autoimmune diseases, the specific ovarian antigens involved in human autoimmune premature ovarian failure have not yet been identified.<xref rid="ame212477-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref>, <xref rid="ame212477-bib-0165" ref-type="bibr">
<sup>165</sup>
</xref> Neonatal thymectomy in mice can create a disease with symptoms similar to human POF [10, 11]. Data from Tang et&#x000a0;al.'s study show that removal of thymus from 2&#x02010; to 4&#x02010;day&#x02010;old mice with autoimmune oophoritis results in complete loss of oocytes and follicles in adult mice [9]. When B6A mice are thymectomized 3&#x02009;days after birth, 90% develop autoimmune euphoritis and premature ovarian failure.<xref rid="ame212477-bib-0166" ref-type="bibr">
<sup>166</sup>
</xref>, <xref rid="ame212477-bib-0167" ref-type="bibr">
<sup>167</sup>
</xref> However, removing the thymus from newborn mice is difficult and has a high mortality rate.<xref rid="ame212477-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref>
</p></sec><sec id="ame212477-sec-0021"><label>2.10</label><title>Psychological stress POF model</title><p>Psychological stress, for example, chronic anxiety, sadness, fear, and other negative emotions, can lead to POF and hypothalamic&#x02013;pituitary&#x02010;ovarian (HPO) axis dysfunction by changing the function of the hypothalamus&#x02010;pituitary target gland axis. Failure to regulate the hypothalamic&#x02013;pituitary&#x02010;ovarian axis feedback disrupts the balance of the neuroendocrine&#x02010;immune biomolecular network and ultimately leads to POF. An animal model of POF stress can be induced by alternately applying different frequencies of electro&#x02010;acoustic stimulation.<xref rid="ame212477-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Mechanistically, when people experience psychological stress, the hypothalamic&#x02013;pituitary&#x02013;adrenal (HPA) axis is activated, leading to the release of high levels of corticotropin&#x02010;releasing hormone (CRH) in the hypothalamus and synthesizing and secreting adrenocorticotropic hormone (ACTH) in the pituitary, which subsequently leads to glucocorticoid release into the bloodstream. The gonadotropin&#x02010;releasing hormone (GnRH) released by the hypothalamus enters through the pituitary portal venous system, triggering the release of FSH and LH.<xref rid="ame212477-bib-0168" ref-type="bibr">
<sup>168</sup>
</xref> Glucocorticoids, responsible for regulating the HPA axis via a negative feedback loop, can disrupt ovarian function by suppressing the synthesis and release of GnRH in the hypothalamus, which leads to a decrease in the production of LH and FSH in the pituitary gland and terminates the stress response.<xref rid="ame212477-bib-0169" ref-type="bibr">
<sup>169</sup>
</xref>, <xref rid="ame212477-bib-0170" ref-type="bibr">
<sup>170</sup>
</xref> The HPA axis activation inhibits the normal functioning of the HPO axis through endocrine, paracrine, and neurological mechanisms.<xref rid="ame212477-bib-0171" ref-type="bibr">
<sup>171</sup>
</xref> As a result, psychological stress can cause changes in reproductive endocrine glands. As well as being involved in the stress response, the reproductive endocrine system is vulnerable to damage caused by psychological stress and can disrupt the neuroendocrine&#x02010;immune network.<xref rid="ame212477-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Chronic unpredictable mild stress (CUMS) induces psychological stress and decreases ovarian reserve in female rats. In addition, granulosa cells underwent more apoptosis in response to psychological stress.<xref rid="ame212477-bib-0165" ref-type="bibr">
<sup>165</sup>
</xref> The decrease in ovarian function is commonly attributed to oxidative stress, follicular atresia, and excessive activation of primordial follicles. The apoptosis of ovarian granulosa cells and oocytes is the primary reason for follicular atresia. Psychological stress&#x02010;induced POF is closely tied to these mechanisms.<xref rid="ame212477-bib-0171" ref-type="bibr">
<sup>171</sup>
</xref> Previous studies have established that, in the ovaries of depressed&#x02010;looking mice, more granulosa cell apoptosis occurs and Bcl2 expression in granulosa cells mitochondria is significantly reduced.<xref rid="ame212477-bib-0172" ref-type="bibr">
<sup>172</sup>
</xref> Oxidative stress induced by psychological stressors can lead to damage to the ovaries by raising levels of ROS. Stress can decrease the levels of antioxidant enzymes, resulting in a notable reduction in the activities of SOD, GPX, and CAT in the preantral follicles<xref rid="ame212477-bib-0173" ref-type="bibr">
<sup>173</sup>
</xref> (Figure&#x000a0;<xref rid="ame212477-fig-0005" ref-type="fig">5</xref>). The advantages of this modeling approach are that it is consistent with the known main causes of human POF and that the pathogenic pathways and pathological changes are similar to clinical observations.<xref rid="ame212477-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref>
</p><fig position="float" fig-type="FIGURE" id="ame212477-fig-0005"><label>FIGURE 5</label><caption><p>Psychological stress regulates ovarian function through the HPA and HPO axes. HPA axis: Stress exposure activates CRH and ACTH in the pituitary, which subsequently stimulates glucocorticoid secretion from the adrenal cortex. Glucocorticoids, acting via a negative feedback loop, can disrupt ovarian function by suppressing the synthesis and release of GnRH in the hypothalamus. HPO axis: GnRH released by the hypothalamus enters through the pituitary portal venous system, triggering the release of FSH and LH. Psychological stressors and disturbances in the path of these axes through oxidative stress, apoptosis of granulosa cells and oocytes, and excessive activation of primary follicles cause a decrease in ovarian function. ACTH, Adrenocorticotropic hormone; CRH, Corticotropin&#x02010;releasing hormone; GnRH, Gonadotropin&#x02010;releasing hormone; HPA, Hypothalamic&#x02013;pituitary&#x02013;adrenal axis; HPO, Hypothalamic&#x02013;pituitary&#x02010;ovarian axis. Created with <ext-link xlink:href="http://biorender.com" ext-link-type="uri">BioRender.com</ext-link>.</p></caption><graphic xlink:href="AME2-7-835-g006" position="anchor" id="jats-graphic-11"/></fig></sec></sec><sec sec-type="discussion" id="ame212477-sec-0022"><label>3</label><title>DISCUSSION</title><p>Many studies have used animal models of POF to investigate and identify the mechanisms of POF and develop therapeutic agents. Inducing an animal model of premature ovarian failure using a gonadotoxic agent without serious damage to other organs is challenging. However, understanding the mechanism of POF development is vital for the clinical treatment of this disease, and considering the limitations to conducting comprehensive studies in humans, animal models such as mice and rats are a powerful tool for finding the pathogenesis of this disease. In this article, we have reviewed the studies that used murine POF models. Mice and rats are the most common animal models used in laboratories to study POF<xref rid="ame212477-bib-0174" ref-type="bibr">
<sup>174</sup>
</xref> because their estrous cycle is similar to that of humans, though considerably shorter. Ninety&#x02010;nine per cent of mouse genes are homologous to human genes, and there is a high degree of similarity in ovarian development processes and functions, as well as in regulation of the genetic pathway responsible for POF, between mice and rats and humans.<xref rid="ame212477-bib-0174" ref-type="bibr">
<sup>174</sup>
</xref>, <xref rid="ame212477-bib-0175" ref-type="bibr">
<sup>175</sup>
</xref>
</p><p>To ensure the establishment of an animal model of POF, the evaluation indicators mainly include hormonal analysis, histological assessment (ovarian weight, follicle count, ovarian reserve, estrous cycle, histopathology), and fertility index.</p><p>Measurement of hormonal levels, such as FSH, LH, AMH, and estradiol, is an important evaluation index for animal models of POF. FSH and LH levels typically increase in POF, while estradiol and AMH levels decrease. Low AMH indicates a decrease in ovarian reserve function.<xref rid="ame212477-bib-0148" ref-type="bibr">
<sup>148</sup>
</xref> These hormonal changes can be measured in the serum or plasma of animals and can provide important insight into the pathogenesis of POF.<xref rid="ame212477-bib-0084" ref-type="bibr">
<sup>84</sup>
</xref>, <xref rid="ame212477-bib-0176" ref-type="bibr">
<sup>176</sup>
</xref>, <xref rid="ame212477-bib-0177" ref-type="bibr">
<sup>177</sup>
</xref>
</p><p>Ovarian histology is an essential evaluation index of POF in animal model. Ovarian reserve refers to the primordial follicles in the ovarian cortex.<xref rid="ame212477-bib-0148" ref-type="bibr">
<sup>148</sup>
</xref>, <xref rid="ame212477-bib-0177" ref-type="bibr">
<sup>177</sup>
</xref> Ovarian reserve tests are performed by direct or indirect evaluation of the reduction in the number of primordial follicles, AFC and AMH.<xref rid="ame212477-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>, <xref rid="ame212477-bib-0178" ref-type="bibr">
<sup>178</sup>
</xref> Histological evaluation includes ovarian volume and weight, corpus luteum number, length of the estrous cycle, number of follicles, ratio of ovulation, and abnormal ovulation.<xref rid="ame212477-bib-0146" ref-type="bibr">
<sup>146</sup>
</xref> In the ovarian tissues of the POF animal model, the volume and weight of the ovary are reduced, the corpus luteum, the ratio of the number of ovulation and normal ovulation is lower, and the estrous cycle is prolonged. In addition, primordial follicles, secondary follicles, and antral follicles are reduced, but atresia and apoptotic follicles are increased.<xref rid="ame212477-bib-0179" ref-type="bibr">
<sup>179</sup>
</xref>
</p><p>Infertility in POF is caused by decreased ovarian reserve function. Fertility is, therefore, a critical evaluation index of POF animal models. Animal models of POF are often evaluated for their ability to conceive and produce offspring. The fertility of POF animals can be assessed by mating them with fertile males and monitoring their pregnancy outcomes (number of pups, pregnancy rate, litter size, abortion, stillbirth).<xref rid="ame212477-bib-0146" ref-type="bibr">
<sup>146</sup>
</xref>, <xref rid="ame212477-bib-0180" ref-type="bibr">
<sup>180</sup>
</xref>, <xref rid="ame212477-bib-0181" ref-type="bibr">
<sup>181</sup>
</xref> Fertility assessment is an essential evaluation index of the POF animal model, as it provides information on the reproductive performance of the animals.</p><p>Using these evaluation indices, researchers can better understand the pathogenesis of POF and develop more effective treatments for this complex condition. Consequently, it is critical to evaluate animal models of POF to ensure that they accurately represent the human condition and can be used to develop effective treatments. On the other hand, the main issue in the POF condition is whether the condition will be reversible after the appearance of the POF. Spontaneous pregnancy is extremely rare in patients with POF. Women who experience POF have menstrual irregularities that interfere with their fertility. Some patients with idiopathic POF show intermittent ovarian function and hence, their chance of spontaneous pregnancy and having an uneventful pregnancy is approximately 5% [1]. Depending on whether the amenorrhea is primary or secondary, POI is reversible. Primary amenorrhea is more serious than secondary amenorrhea, and the latter is easier to reverse. The results of laboratory tests for FSH, estradiol, and inhibin B can predict the chance of POI reversal [2]. Therefore, we call attention to the reversibility and irreversibility of animal POF models. For example, in both the genetic model and the oophorectomy model, it is not possible to reverse POF, while in models induced by chemotherapy, radiotherapy, and natural aging, it is possible to reverse ovarian activity due to the presence of ovarian stem cells, including very small embryonic&#x02010;like stem cells or VSELs, which are resistant to chemotherapy and radiotherapy. [1] and have also been observed in the ovaries of postmenopausal women [2].</p><p>Animal model studies provide an easier and more effective way to understand the occurrence and development of human diseases, but different methods of creating POF animal models have their advantages and disadvantages. Advantages of the chemotherapy&#x02010;induced POF animal model include a simple operation, low cost, short cycle and low mortality. Bleeding and myelosuppression are also side effects of the CTX&#x02010;induced POF animal model.<xref rid="ame212477-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref> Previous research has shown that about 10% to 30% of POF disorders are caused by autoimmune mechanisms.<xref rid="ame212477-bib-0182" ref-type="bibr">
<sup>182</sup>
</xref> However, the stability of animal models of autoimmunity&#x02010; and mental stress&#x02010;induced POF is low. A GAL&#x02010;induced animal model can mimic the features of physiological aging in patients with POF, but the success rate is lower, and the cycle time is longer.<xref rid="ame212477-bib-0140" ref-type="bibr">
<sup>140</sup>
</xref> Therefore, choosing the ideal animal model for studying drug intervention and disease mechanisms is still a big challenge, and appropriate models should be selected according to the study's main purpose.</p><p>The most common causes of POF are exposure to chemotherapy and radiation therapy and the most common model of POF is induced by chemotherapy drugs. Chemotherapy&#x02010;related ovarian failure (COF) refers to ovarian endocrine and fertility dysfunction after exposure to chemotherapy drugs. Besides directly affecting follicles and eggs, chemotherapy may cause ovarian toxicity by affecting the entire ovary. Also, alkylating agents, the most toxic chemotherapy drugs, acting in a dose&#x02010;dependent manner, cause direct destruction of eggs and follicular emptying and may cause fibrosis and damage to ovarian blood vessels.<xref rid="ame212477-bib-0183" ref-type="bibr">
<sup>183</sup>
</xref> Cyclophosphamide is the most gonadotoxic drug, and is also used in the clinic as the first line of chemotherapy drugs. It has been more widely used that other methods to create animal models. The therapeutic and toxic effects of cyclophosphamide are related to its active metabolites, such as acrolein and phosphoramide mustard. These metabolites bind to DNA and lead to disruption of DNA synthesis and cell death,<xref rid="ame212477-bib-0184" ref-type="bibr">
<sup>184</sup>
</xref> which has harmful toxic consequences for cells in organs such as the heart, liver, and kidney and has severe toxic effects on the ovary.<xref rid="ame212477-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref>, <xref rid="ame212477-bib-0185" ref-type="bibr">
<sup>185</sup>
</xref> CTX is the first chemotherapy drug to be associated with amenorrhea/POF and ovarian dysfunction<xref rid="ame212477-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> and is also considered one of the most important gonadotoxic agents.<xref rid="ame212477-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Cyclophosphamide accelerates the maturation process of ovarian follicles into mature follicles, reduces ovarian reserves, and ultimately leads to premature ovarian failure in young female patients.<xref rid="ame212477-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="ame212477-bib-0186" ref-type="bibr">
<sup>186</sup>
</xref> There is clear evidence that CTX leads to an up&#x02010;regulation of apoptosis in the ovary, as evidenced by rapid induction of DNA breaks<xref rid="ame212477-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> and altered expression levels of pro&#x02010;apoptotic and anti&#x02010;apoptotic genes.<xref rid="ame212477-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>
</p><p>The classic animal model for studying POF is created using chemotherapy drugs. The most common animal model of POF is induced by cyclophosphamide, and its toxic effect on the ovaries has been confirmed.<xref rid="ame212477-bib-0187" ref-type="bibr">
<sup>187</sup>
</xref> Previous studies have shown that to create the most effective POF model, cyclophosphamide (120&#x02009;mg/kg) must be used for at least 2&#x02009;weeks and cisplatin (2&#x02009;mg/kg) for more than ten days is recommended.<xref rid="ame212477-bib-0089" ref-type="bibr">
<sup>89</sup>
</xref> In the study of Bahrebar et&#x000a0;al., different concentrations of two chemotherapy drugs, cyclophosphamide, and busulfan, were investigated in order to create a POF model, and the use of 100&#x02009;mg/kg CTX alone for ten consecutive days was chosen as the most effective POF induction model.<xref rid="ame212477-bib-0090" ref-type="bibr">
<sup>90</sup>
</xref> In a meta&#x02010;analysis article, it has been shown that a 200&#x02009;mg/kg dose with an 8&#x02009;mg/kg maintenance dose of CTX for 14 consecutive days has the best efficacy in creating a CTX&#x02010;induced POF model. Cyclophosphamide has been used in many studies as a gonadotoxic chemotherapy drug to induce the POF model in mice and rats, as summarized in Table&#x000a0;<xref rid="ame212477-tbl-0002" ref-type="table">2</xref>. Therefore, we suggest using cyclophosphamide to create an effective murine POF model. However, it is important to note that the choice of drugs may depend on the specific research objectives. On the other hand, the reported rates of premature ovarian failure models using chemotherapy drugs are very different and mainly rely on the chemotherapy protocols. The treatment depends on the number of injections, the age range, and the breed of the animal.</p><table-wrap position="float" id="ame212477-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Murine POF model induced by chemotherapy drugs.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Row</th><th align="left" valign="bottom" rowspan="1" colspan="1">Species</th><th align="left" valign="bottom" rowspan="1" colspan="1">Chemotherapy drug (dose)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Reference</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">ICR mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (75&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0038" ref-type="bibr">38</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (75&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0043" ref-type="bibr">43</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 male &#x000d7; Balb/c female mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (75&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0036" ref-type="bibr">36</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">Balb/c mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (75&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0039" ref-type="bibr">39</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (100&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0040" ref-type="bibr">40</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">SD rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (100&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0023" ref-type="bibr">23</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">CD&#x02010;1 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (100&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0054" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">Kunming white mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (120&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0188" ref-type="bibr">188</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">Albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (150&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0010" ref-type="bibr">10</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (150&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0044" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="left" valign="top" rowspan="1" colspan="1">Mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (150&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0042" ref-type="bibr">42</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">Wister albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (150&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0049" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">Wister albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (150&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0051" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">Wister albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (150&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0050" ref-type="bibr">50</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">B6D2F1 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (50&#x02009;mg/kg/14&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0053" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">SD rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (50&#x02009;mg/kg/1&#x02009;day 8&#x02009;mg/kg/14&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0048" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="left" valign="top" rowspan="1" colspan="1">Wister albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (50&#x02009;mg/kg/1&#x02009;day 8&#x02009;mg/kg/14&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0041" ref-type="bibr">41</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="left" valign="top" rowspan="1" colspan="1">Wister albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (50&#x02009;mg/kg/1&#x02009;day 8&#x02009;mg/kg/14&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0022" ref-type="bibr">22</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">19</td><td align="left" valign="top" rowspan="1" colspan="1">Albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (200&#x02009;mg/kg/1&#x02009;day 8&#x02009;mg/kg/14&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0052" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="left" valign="top" rowspan="1" colspan="1">Albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (200&#x02009;mg/kg/1&#x02009;day 8&#x02009;mg/kg/14&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0004" ref-type="bibr">4</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="left" valign="top" rowspan="1" colspan="1">Albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (200&#x02009;mg/kg/1&#x02009;day 8&#x02009;mg/kg/14&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0047" ref-type="bibr">47</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">22</td><td align="left" valign="top" rowspan="1" colspan="1">BALB/c mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (75&#x02009;100&#x02009;150&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0045" ref-type="bibr">45</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="left" valign="top" rowspan="1" colspan="1">CD&#x02010;1 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (75, 150&#x02009;250&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0025" ref-type="bibr">25</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">24</td><td align="left" valign="top" rowspan="1" colspan="1">NMRI mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (200&#x02009;mg/kg/3&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0021" ref-type="bibr">21</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (300&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0026" ref-type="bibr">26</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (1.2&#x02009;mg/kg/14&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0037" ref-type="bibr">37</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">27</td><td align="left" valign="top" rowspan="1" colspan="1">SPF mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (120&#x02009;mg/kg) + Busulfan (30&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0085" ref-type="bibr">85</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">28</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (120&#x02009;mg/kg) + Busulfan (30&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0087" ref-type="bibr">87</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">29</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (120&#x02009;mg/kg) + Busulfan (30&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0088" ref-type="bibr">88</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="left" valign="top" rowspan="1" colspan="1">CD&#x02010;1 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (120&#x02009;mg/kg) + Busulfan (12&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0086" ref-type="bibr">86</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">31</td><td align="left" valign="top" rowspan="1" colspan="1">ICR mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (120&#x02009;mg/kg) + Busulfan (12&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0187" ref-type="bibr">187</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">32</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclophosphamide (120&#x02009;mg/kg) + Busulfan (12&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0089" ref-type="bibr">89</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">33</td><td align="left" valign="top" rowspan="1" colspan="1">Rat</td><td align="left" valign="top" rowspan="1" colspan="1">Cisplatin (5&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0068" ref-type="bibr">68</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="left" valign="top" rowspan="1" colspan="1">Swiss mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cisplatin (5&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0064" ref-type="bibr">64</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">35</td><td align="left" valign="top" rowspan="1" colspan="1">Wister albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cisplatin (5&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0071" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="left" valign="top" rowspan="1" colspan="1">CD&#x02010;1 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cisplatin (5&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0061" ref-type="bibr">61</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">37</td><td align="left" valign="top" rowspan="1" colspan="1">Wister albino rats</td><td align="left" valign="top" rowspan="1" colspan="1">Cisplatin (1.5&#x02009;mg/kg/10&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0063" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="left" valign="top" rowspan="1" colspan="1">CD&#x02010;1 (ICR) mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cisplatin (2.5&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0069" ref-type="bibr">69</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="left" valign="top" rowspan="1" colspan="1">ICR mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cisplatin (2&#x02009;mg/kg/15&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0067" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cisplatin (2&#x02009;mg/kg/10&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0089" ref-type="bibr">89</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">41</td><td align="left" valign="top" rowspan="1" colspan="1">C57BL/6 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cisplatin (2&#x02009;mg/kg/21&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0189" ref-type="bibr">189</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">42</td><td align="left" valign="top" rowspan="1" colspan="1">CD&#x02010;1 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Cisplatin (2&#x02009;mg/kg/15&#x02009;days 5&#x02009;mg/kg/8&#x02009;days)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0070" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">43</td><td align="left" valign="top" rowspan="1" colspan="1">ICR mice</td><td align="left" valign="top" rowspan="1" colspan="1">Doxorubicin (7.5&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0083" ref-type="bibr">83</xref>]</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">44</td><td align="left" valign="top" rowspan="1" colspan="1">CD&#x02010;1 mice</td><td align="left" valign="top" rowspan="1" colspan="1">Doxorubicin (20&#x02009;mg/kg)</td><td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="ame212477-bib-0079" ref-type="bibr">79</xref>]</td></tr></tbody></table><table-wrap-foot id="ame212477-ntgp-0001"><fn id="ame212477-note-0001"><p>Abbreviation: POF, premature ovarian failure.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="conclusions" id="ame212477-sec-0023"><label>4</label><title>CONCLUSION</title><p>In conclusion, animal POF models can help us understand the molecular mechanisms involved in the human disease better. According to the studies outlined, the most practical method to create an animal model of premature ovarian failure is to use cyclophosphamide because it causes the least damage to the animal and the death rate is lower. Although animal models of POF using chemotherapy drugs do not provide a complete picture of this disease, they are still an effective method of studying the disease and preventing the damage to ovarian function associated with chemotherapy. This review may help future researchers establish the most effective animal model of POF to develop therapeutic approaches and study the function and mechanism of POF. However, more studies are needed to choose the best POF model in different species and to find the most effective dose and frequency of injection.</p></sec><sec id="ame212477-sec-0024"><title>AUTHOR CONTRIBUTIONS</title><p>N.P. collected previous literature and wrote the manuscript. M.A. and H.Z. read and agreed to the final manuscript. R.F. reviewed and revised the manuscript. S.T. conceived the purpose and concept of the study, revised and finalized the manuscript. All authors read and approved the final manuscript.</p></sec><sec id="ame212477-sec-0026"><title>FUNDING INFORMATION</title><p>This research did not receive any specific grant from funding agencies in the public, commercial or not&#x02010;for&#x02010;profit sectors.</p></sec><sec sec-type="COI-statement" id="ame212477-sec-0027"><title>CONFLICT OF INTEREST STATEMENT</title><p>The authors declare no competing interests.</p></sec><sec id="ame212477-sec-0030"><title>ETHICS STATEMENT</title><p>None.</p></sec></body><back><ack id="ame212477-sec-0025"><title>ACKNOWLEDGMENTS</title><p>The authors are thankful to the Reproductive Biomedicine Research Center, Royan Institute, Tehran.</p></ack><sec sec-type="data-availability" id="ame212477-sec-0029"><title>DATA AVAILABILITY STATEMENT</title><p>No data was used for the research described in the article.</p></sec><ref-list content-type="cited-references" id="ame212477-bibl-0001"><title>REFERENCES</title><ref id="ame212477-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="ame212477-cit-0001">
<string-name>
<surname>Pastore</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Christianson</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Stelling</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kearns</surname>
<given-names>WG</given-names>
</string-name>, <string-name>
<surname>Segars</surname>
<given-names>JH</given-names>
</string-name>. <article-title>Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR</article-title>. <source>J Assist Reprod Genet</source>. <year>2018</year>;<volume>35</volume>(<issue>1</issue>):<fpage>17</fpage>&#x02010;<lpage>23</lpage>.<pub-id pub-id-type="pmid">28971280</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="ame212477-cit-0002">
<string-name>
<surname>Coulam</surname>
<given-names>CB</given-names>
</string-name>. <article-title>Premature gonadal failure</article-title>. <source>Fertil Steril</source>. <year>1982</year>;<volume>38</volume>(<issue>6</issue>):<fpage>645</fpage>&#x02010;<lpage>655</lpage>.<pub-id pub-id-type="pmid">7141005</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="ame212477-cit-0003">
<string-name>
<surname>Vujovic</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Brincat</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Erel</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>EMAS position statement: managing women with premature ovarian failure</article-title>. <source>Maturitas</source>. <year>2010</year>;<volume>67</volume>(<issue>1</issue>):<fpage>91</fpage>&#x02010;<lpage>93</lpage>.<pub-id pub-id-type="pmid">20605383</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="ame212477-cit-0004">
<string-name>
<surname>Abdelzaher</surname>
<given-names>WY</given-names>
</string-name>, <string-name>
<surname>Abdel&#x02010;Hafez</surname>
<given-names>SMN</given-names>
</string-name>, <string-name>
<surname>Rofaeil</surname>
<given-names>RR</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hegazy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bahaa</surname>
<given-names>HA</given-names>
</string-name>. <article-title>The protective effect of fenofibrate, triptorelin, and their combination against premature ovarian failure in rats</article-title>. <source>Naunyn Schmiedeberg's Arch Pharmacol</source>. <year>2021</year>;<volume>394</volume>(<issue>1</issue>):<fpage>137</fpage>&#x02010;<lpage>149</lpage>.<pub-id pub-id-type="pmid">32924068</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="ame212477-cit-0005">
<string-name>
<surname>Podfigurna&#x02010;Stopa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Czyzyk</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Grymowicz</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Premature ovarian insufficiency: the context of long&#x02010;term effects</article-title>. <source>J Endocrinol Investig</source>. <year>2016</year>;<volume>39</volume>(<issue>9</issue>):<fpage>983</fpage>&#x02010;<lpage>990</lpage>.<pub-id pub-id-type="pmid">27091671</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="ame212477-cit-0006">
<string-name>
<surname>Elkady</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Shalaby</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Fathi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>El&#x02010;Mandouh</surname>
<given-names>S</given-names>
</string-name>. <article-title>Effects of quercetin and rosuvastatin each alone or in combination on cyclophosphamide&#x02010;induced premature ovarian failure in female albino mice</article-title>. <source>Hum Exp Toxicol</source>. <year>2019</year>;<volume>38</volume>(<issue>11</issue>):<fpage>1283</fpage>&#x02010;<lpage>1295</lpage>.<pub-id pub-id-type="pmid">31370695</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="ame212477-cit-0007">
<string-name>
<surname>Wang</surname>
<given-names>XF</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>QH</given-names>
</string-name>, <string-name>
<surname>Min</surname>
<given-names>JX</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>LC</given-names>
</string-name>. <article-title>Biological mechanisms of premature ovarian failure caused by psychological stress based on support vector regression</article-title>. <source>Int J Clin Exp Med</source>. <year>2015</year>;<volume>8</volume>(<issue>11</issue>):<fpage>21393</fpage>&#x02010;<lpage>21399</lpage>.<pub-id pub-id-type="pmid">26885082</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="ame212477-cit-0008">
<string-name>
<surname>Pouresmaeili</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Fazeli</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Premature ovarian failure: a critical condition in the reproductive potential with various genetic causes</article-title>. <source>Int J Fertil Steril</source>. <year>2014</year>;<volume>8</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02010;<lpage>12</lpage>.<pub-id pub-id-type="pmid">24696764</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="ame212477-cit-0009">
<string-name>
<surname>Yang</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>JQ</given-names>
</string-name>, <string-name>
<surname>Fei</surname>
<given-names>YF</given-names>
</string-name>. <article-title>Lycium barbarum polysaccharide attenuates chemotherapy&#x02010;induced ovarian injury by reducing oxidative stress</article-title>. <source>J Obstet Gynaecol Res</source>. <year>2017</year>;<volume>43</volume>(<issue>10</issue>):<fpage>1621</fpage>&#x02010;<lpage>1628</lpage>.<pub-id pub-id-type="pmid">28817219</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="ame212477-cit-0010">
<string-name>
<surname>Abdel&#x02010;Aziz</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Mohamed</surname>
<given-names>ASM</given-names>
</string-name>, <string-name>
<surname>Abdelazem</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Okasha</surname>
<given-names>AMM</given-names>
</string-name>, <string-name>
<surname>Kamel</surname>
<given-names>MY</given-names>
</string-name>. <article-title>Cilostazol protects against cyclophosphamide&#x02010;induced ovarian toxicity in female rats: role of cAMP and HO&#x02010;1</article-title>. <source>Toxicol Mech Methods</source>. <year>2020</year>;<volume>30</volume>(<issue>7</issue>):<fpage>526</fpage>&#x02010;<lpage>535</lpage>.<pub-id pub-id-type="pmid">32456565</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="ame212477-cit-0011">
<string-name>
<surname>Okada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Fujisawa</surname>
<given-names>M</given-names>
</string-name>. <article-title>Recovery of spermatogenesis following cancer treatment with cytotoxic chemotherapy and radiotherapy. The world</article-title>. <source>J Mens Health</source>. <year>2019</year>;<volume>37</volume>(<issue>2</issue>):<fpage>166</fpage>&#x02010;<lpage>174</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="ame212477-cit-0012">
<string-name>
<surname>Bedoschi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Navarro</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Oktay</surname>
<given-names>K</given-names>
</string-name>. <article-title>Chemotherapy&#x02010;induced damage to ovary: mechanisms and clinical impact</article-title>. <source>Future Oncol</source>. <year>2016</year>;<volume>12</volume>(<issue>20</issue>):<fpage>2333</fpage>&#x02010;<lpage>2344</lpage>.<pub-id pub-id-type="pmid">27402553</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="ame212477-cit-0013">
<string-name>
<surname>Kim</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>SJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Molecular mechanism and prevention strategy of chemotherapy&#x02010; and radiotherapy&#x02010;induced ovarian damage</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<volume>22</volume>(<issue>14</issue>):<fpage>7484</fpage>.<pub-id pub-id-type="pmid">34299104</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="ame212477-cit-0014">
<string-name>
<surname>Di Giacomo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Barchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Baudat</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Edelmann</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Keeney</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jasin</surname>
<given-names>M</given-names>
</string-name>. <article-title>Distinct DNA&#x02010;damage&#x02010;dependent and &#x02010;independent responses drive the loss of oocytes in recombination&#x02010;defective mouse mutants</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2005</year>;<volume>102</volume>(<issue>3</issue>):<fpage>737</fpage>&#x02010;<lpage>742</lpage>.<pub-id pub-id-type="pmid">15640358</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="ame212477-cit-0015">
<string-name>
<surname>Perez</surname>
<given-names>GI</given-names>
</string-name>, <string-name>
<surname>Acton</surname>
<given-names>BM</given-names>
</string-name>, <string-name>
<surname>Jurisicova</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Genetic variance modifies apoptosis susceptibility in mature oocytes via alterations in DNA repair capacity and mitochondrial ultrastructure</article-title>. <source>Cell Death Differ</source>. <year>2007</year>;<volume>14</volume>(<issue>3</issue>):<fpage>524</fpage>&#x02010;<lpage>533</lpage>.<pub-id pub-id-type="pmid">17039249</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="ame212477-cit-0016">
<string-name>
<surname>Spears</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Lopes</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Stefansdottir</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Ovarian damage from chemotherapy and current approaches to its protection</article-title>. <source>Hum Reprod Update</source>. <year>2019</year>;<volume>25</volume>(<issue>6</issue>):<fpage>673</fpage>&#x02010;<lpage>693</lpage>.<pub-id pub-id-type="pmid">31600388</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="ame212477-cit-0017">
<string-name>
<surname>Akyol</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gulec</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Erdemli</surname>
<given-names>HK</given-names>
</string-name>, <string-name>
<surname>Akyol</surname>
<given-names>O</given-names>
</string-name>. <article-title>Can propolis and caffeic acid phenethyl ester be promising agents against cyclophosphamide toxicity?</article-title>
<source>J Intercult Ethnopharmacol</source>. <year>2016</year>;<volume>5</volume>(<issue>1</issue>):<fpage>105</fpage>&#x02010;<lpage>107</lpage>.<pub-id pub-id-type="pmid">27069732</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="ame212477-cit-0018">
<string-name>
<surname>Barberino</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Silva</surname>
<given-names>RLS</given-names>
</string-name>, <string-name>
<surname>Palheta Junior</surname>
<given-names>RC</given-names>
</string-name>, <string-name>
<surname>Smitz</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Matos</surname>
<given-names>MHT</given-names>
</string-name>. <article-title>Protective effects of antioxidants on cyclophosphamide&#x02010;induced ovarian toxicity</article-title>. <source>Biopreserv Biobank</source>. <year>2023</year>;<volume>21</volume>(<issue>2</issue>):<fpage>121</fpage>&#x02010;<lpage>141</lpage>.<pub-id pub-id-type="pmid">35696235</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="ame212477-cit-0019">
<string-name>
<surname>Overbeek</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>van den Berg</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>van Leeuwen</surname>
<given-names>FE</given-names>
</string-name>, <string-name>
<surname>Kaspers</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Lambalk</surname>
<given-names>CB</given-names>
</string-name>, <string-name>
<surname>van Dulmen&#x02010;den</surname>
<given-names>BE</given-names>
</string-name>. <article-title>Chemotherapy&#x02010;related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review</article-title>. <source>Cancer Treat Rev</source>. <year>2017</year>;<volume>53</volume>:<fpage>10</fpage>&#x02010;<lpage>24</lpage>.<pub-id pub-id-type="pmid">28056411</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="ame212477-cit-0020">
<string-name>
<surname>Piasecka&#x02010;Srader</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Blanco</surname>
<given-names>FF</given-names>
</string-name>, <string-name>
<surname>Delman</surname>
<given-names>DH</given-names>
</string-name>, et&#x000a0;al. <article-title>Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat Ovaries1</article-title>. <source>Biol Reprod</source>. <year>2015</year>;<volume>92</volume>(<issue>5</issue>):<elocation-id>132</elocation-id>.<pub-id pub-id-type="pmid">25833159</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="ame212477-cit-0021">
<string-name>
<surname>Hassanpour</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Yousefian</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Askaripour</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sharififar</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Ezzatabadipour</surname>
<given-names>M</given-names>
</string-name>. <article-title>Ovarian protection in cyclophosphamide&#x02010;treated mice by fennel</article-title>. <source>Toxicol Rep</source>. <year>2017</year>;<volume>4</volume>:<fpage>160</fpage>&#x02010;<lpage>164</lpage>.<pub-id pub-id-type="pmid">28959636</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="ame212477-cit-0022">
<string-name>
<surname>Mobasher</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Hassen</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Ebiya</surname>
<given-names>RA</given-names>
</string-name>, et&#x000a0;al. <article-title>Ameliorative effect of citrus lemon Peel extract and resveratrol on premature ovarian failure rat model: role of iNOS/Caspase&#x02010;3 pathway</article-title>. <source>Molecules</source>. <year>2022</year>;<volume>28</volume>(<issue>1</issue>):<fpage>122</fpage>.<pub-id pub-id-type="pmid">36615313</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="ame212477-cit-0023">
<string-name>
<surname>Zheng</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>. <article-title>Effects of quercetin on ovarian function and regulation of the ovarian PI3K/Akt/FoxO3a signalling pathway and oxidative stress in a rat model of cyclophosphamide&#x02010;induced premature ovarian failure</article-title>. <source>Basic Clin Pharmacol Toxicol</source>. <year>2022</year>;<volume>130</volume>(<issue>2</issue>):<fpage>240</fpage>&#x02010;<lpage>253</lpage>.<pub-id pub-id-type="pmid">34841658</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="ame212477-cit-0024">
<string-name>
<surname>Huang</surname>
<given-names>CC</given-names>
</string-name>, <string-name>
<surname>Chou</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>YS</given-names>
</string-name>, et&#x000a0;al. <article-title>Metformin: a novel promising option for fertility preservation during cyclophosphamide&#x02010;based chemotherapy</article-title>. <source>Mol Hum Reprod</source>. <year>2021</year>;<volume>27</volume>(<issue>1</issue>):<fpage>gaaa084</fpage>.<pub-id pub-id-type="pmid">33543290</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="ame212477-cit-0025">
<string-name>
<surname>Petrillo</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Desmeules</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Truong</surname>
<given-names>TQ</given-names>
</string-name>, <string-name>
<surname>Devine</surname>
<given-names>PJ</given-names>
</string-name>. <article-title>Detection of DNA damage in oocytes of small ovarian follicles following phosphoramide mustard exposures of cultured rodent ovaries in&#x000a0;vitro</article-title>. <source>Toxicol Appl Pharmacol</source>. <year>2011</year>;<volume>253</volume>(<issue>2</issue>):<fpage>94</fpage>&#x02010;<lpage>102</lpage>.<pub-id pub-id-type="pmid">21439308</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="ame212477-cit-0026">
<string-name>
<surname>Nguyen</surname>
<given-names>Q&#x02010;N</given-names>
</string-name>, <string-name>
<surname>Zerafa</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Liew</surname>
<given-names>SH</given-names>
</string-name>, et&#x000a0;al. <article-title>Loss of PUMA protects the ovarian reserve during DNA&#x02010;damaging chemotherapy and preserves fertility</article-title>. <source>Cell Death Dis</source>. <year>2018</year>;<volume>9</volume>(<issue>6</issue>):<elocation-id>618</elocation-id>.<pub-id pub-id-type="pmid">29795269</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="ame212477-cit-0027">
<string-name>
<surname>Bellusci</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mattiello</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Iannizzotto</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. <article-title>Kinase&#x02010;independent inhibition of cyclophosphamide&#x02010;induced pathways protects the ovarian reserve and prolongs fertility</article-title>. <source>Cell Death Dis</source>. <year>2019</year>;<volume>10</volume>(<issue>10</issue>):<elocation-id>726</elocation-id>.<pub-id pub-id-type="pmid">31562295</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="ame212477-cit-0028">
<string-name>
<surname>Luan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Edmonds</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Woodruff</surname>
<given-names>TK</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SY</given-names>
</string-name>. <article-title>Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide</article-title>. <source>J Endocrinol</source>. <year>2019</year>;<volume>240</volume>(<issue>2</issue>):<fpage>243</fpage>&#x02010;<lpage>256</lpage>.<pub-id pub-id-type="pmid">30530902</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="ame212477-cit-0029">
<string-name>
<surname>Mattiello</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Pucci</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Marchetti</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Diederich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gonfloni</surname>
<given-names>S</given-names>
</string-name>. <article-title>Asciminib mitigates DNA damage stress signaling induced by cyclophosphamide in the ovary</article-title>. <source>Int J Mol Sci</source>. <year>2021</year>;<volume>22</volume>(<issue>3</issue>):<elocation-id>1395</elocation-id>.<pub-id pub-id-type="pmid">33573271</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="ame212477-cit-0030">
<string-name>
<surname>Kurita</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Cunha</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Robboy</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Mills</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Medina</surname>
<given-names>RT</given-names>
</string-name>. <article-title>Differential expression of p63 isoforms in female reproductive organs</article-title>. <source>Mech Dev</source>. <year>2005</year>;<volume>122</volume>(<issue>9</issue>):<fpage>1043</fpage>&#x02010;<lpage>1055</lpage>.<pub-id pub-id-type="pmid">15922574</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="ame212477-cit-0031">
<string-name>
<surname>Suh</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kettenbach</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>p63 protects the female germ line during meiotic arrest</article-title>. <source>Nature</source>. <year>2006</year>;<volume>444</volume>(<issue>7119</issue>):<fpage>624</fpage>&#x02010;<lpage>628</lpage>.<pub-id pub-id-type="pmid">17122775</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="ame212477-cit-0032">
<string-name>
<surname>Wang</surname>
<given-names>XQ</given-names>
</string-name>, <string-name>
<surname>Redpath</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>ST</given-names>
</string-name>, <string-name>
<surname>Stanbridge</surname>
<given-names>EJ</given-names>
</string-name>. <article-title>ATR dependent activation of Chk2</article-title>. <source>J Cell Physiol</source>. <year>2006</year>;<volume>208</volume>(<issue>3</issue>):<fpage>613</fpage>&#x02010;<lpage>619</lpage>.<pub-id pub-id-type="pmid">16741947</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="ame212477-cit-0033">
<string-name>
<surname>Kerr</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Hutt</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Michalak</surname>
<given-names>EM</given-names>
</string-name>, et&#x000a0;al. <article-title>DNA damage&#x02010;induced primordial follicle oocyte apoptosis and loss of fertility require TAp63&#x02010;mediated induction of Puma and Noxa</article-title>. <source>Mol Cell</source>. <year>2012</year>;<volume>48</volume>(<issue>3</issue>):<fpage>343</fpage>&#x02010;<lpage>352</lpage>.<pub-id pub-id-type="pmid">23000175</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="ame212477-cit-0034">
<string-name>
<surname>Emori</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Boucher</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Bolcun&#x02010;Filas</surname>
<given-names>E</given-names>
</string-name>. <article-title>CHEK2 signaling is the key regulator of oocyte survival after chemotherapy</article-title>. <source>Sci Adv</source>. <year>2023</year>;<volume>9</volume>(<issue>42</issue>):<elocation-id>eadg0898</elocation-id>.<pub-id pub-id-type="pmid">37862420</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="ame212477-cit-0035">
<string-name>
<surname>Bolcun&#x02010;Filas</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Rinaldi</surname>
<given-names>VD</given-names>
</string-name>, <string-name>
<surname>White</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Schimenti</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway</article-title>. <source>Science</source>. <year>2014</year>;<volume>343</volume>(<issue>6170</issue>):<fpage>533</fpage>&#x02010;<lpage>536</lpage>.<pub-id pub-id-type="pmid">24482479</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="ame212477-cit-0036">
<string-name>
<surname>Pascuali</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Scotti</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Di Pietro</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Ceramide&#x02010;1&#x02010;phosphate has protective properties against cyclophosphamide&#x02010;induced ovarian damage in a mice model of premature ovarian failure</article-title>. <source>Hum Reprod</source>. <year>2018</year>;<volume>33</volume>(<issue>5</issue>):<fpage>844</fpage>&#x02010;<lpage>859</lpage>.<pub-id pub-id-type="pmid">29534229</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="ame212477-cit-0037">
<string-name>
<surname>Zhang</surname>
<given-names>B&#x02010;f</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>8</issue>):<elocation-id>e0201136</elocation-id>.<pub-id pub-id-type="pmid">30071053</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="ame212477-cit-0038">
<string-name>
<surname>Feng</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>WW</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>HX</given-names>
</string-name>, et&#x000a0;al. <article-title>Melatonin prevents cyclophosphamide&#x02010;induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression</article-title>. <source>Front Endocrinol (Lausanne)</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>895095</elocation-id>.<pub-id pub-id-type="pmid">35992124</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="ame212477-cit-0039">
<string-name>
<surname>Barekati</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Golkar&#x02010;Narenji</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Totonchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Radpour</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gourabi</surname>
<given-names>H</given-names>
</string-name>. <article-title>Effects of amifostine in combination with cyclophosphamide on female reproductive system</article-title>. <source>Reprod Sci</source>. <year>2012</year>;<volume>19</volume>(<issue>5</issue>):<fpage>539</fpage>&#x02010;<lpage>546</lpage>.<pub-id pub-id-type="pmid">22267539</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="ame212477-cit-0040">
<string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Network and experimental pharmacology on mechanism of Si&#x02010;Wu&#x02010;tang improving ovarian function in a mouse model of premature ovarian failure induced by cyclophosphamide</article-title>. <source>J Ethnopharmacol</source>. <year>2023</year>;<volume>301</volume>:<elocation-id>115842</elocation-id>.<pub-id pub-id-type="pmid">36265674</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="ame212477-cit-0041">
<string-name>
<surname>&#x000c7;a&#x0011f;l&#x00131;</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bakt&#x00131;r</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Dolanbay</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>An evaluation of the effects on the ovaries of hyperbaric oxygen therapy in a rat model of premature ovarian failure created with cyclophosphamide</article-title>. <source>Turk J Obstet Gynecol</source>. <year>2023</year>;<volume>20</volume>(<issue>1</issue>):<fpage>46</fpage>&#x02010;<lpage>52</lpage>.<pub-id pub-id-type="pmid">36908093</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="ame212477-cit-0042">
<string-name>
<surname>Kalich&#x02010;Philosoph</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Roness</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Carmely</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Cyclophosphamide triggers follicle activation and &#x0201c;burnout&#x0201d;; AS101 prevents follicle loss and preserves fertility</article-title>. <source>Sci Transl Med</source>. <year>2013</year>;<volume>5</volume>(<issue>185</issue>):<elocation-id>185ra62</elocation-id>.</mixed-citation></ref><ref id="ame212477-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="ame212477-cit-0043">
<string-name>
<surname>Li</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Long</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Cong</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Quercetin prevents primordial follicle loss via suppression of PI3K/Akt/Foxo3a pathway activation in cyclophosphamide&#x02010;treated mice</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2021</year>;<volume>19</volume>(<issue>1</issue>):<elocation-id>63</elocation-id>.<pub-id pub-id-type="pmid">33892727</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="ame212477-cit-0044">
<string-name>
<surname>Goldman</surname>
<given-names>KN</given-names>
</string-name>, <string-name>
<surname>Chenette</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Arju</surname>
<given-names>R</given-names>
</string-name>, et&#x000a0;al. <article-title>mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2017</year>;<volume>114</volume>(<issue>12</issue>):<fpage>3186</fpage>&#x02010;<lpage>3191</lpage>.<pub-id pub-id-type="pmid">28270607</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="ame212477-cit-0045">
<string-name>
<surname>Zhou</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Rapamycin prevents cyclophosphamide&#x02010;induced over&#x02010;activation of primordial follicle pool through PI3K/Akt/mTOR signaling pathway in&#x000a0;vivo</article-title>. <source>J Ovarian Res</source>. <year>2017</year>;<volume>10</volume>(<issue>1</issue>):<elocation-id>56</elocation-id>.<pub-id pub-id-type="pmid">28814333</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="ame212477-cit-0046">
<string-name>
<surname>Jeelani</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Shaeib</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Cyclophosphamide and acrolein induced oxidative stress leading to deterioration of metaphase II mouse oocyte quality</article-title>. <source>Free Radic Biol Med</source>. <year>2017</year>;<volume>110</volume>:<fpage>11</fpage>&#x02010;<lpage>18</lpage>.<pub-id pub-id-type="pmid">28499912</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="ame212477-cit-0047">
<string-name>
<surname>Melekoglu</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ciftci</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Eraslan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cetin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Basak</surname>
<given-names>N</given-names>
</string-name>. <article-title>Beneficial effects of curcumin and capsaicin on cyclophosphamide&#x02010;induced premature ovarian failure in a rat model</article-title>. <source>J Ovarian Res</source>. <year>2018</year>;<volume>11</volume>(<issue>1</issue>):<elocation-id>33</elocation-id>.<pub-id pub-id-type="pmid">29699594</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="ame212477-cit-0048">
<string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Ameliorative effect of recombinant human lactoferrin on the premature ovarian failure in rats after cyclophosphamide treatments</article-title>. <source>J Ovarian Res</source>. <year>2021</year>;<volume>14</volume>(<issue>1</issue>):<elocation-id>17</elocation-id>.<pub-id pub-id-type="pmid">33478578</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="ame212477-cit-0049">
<string-name>
<surname>Hamzeh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hosseinimehr</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Mohammadi</surname>
<given-names>HR</given-names>
</string-name>, <string-name>
<surname>Yaghubi Beklar</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Dashti</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Talebpour</surname>
<given-names>AF</given-names>
</string-name>. <article-title>Atorvastatin attenuates the ovarian damage induced by cyclophosphamide in rat: an experimental study</article-title>. <source>Int J Reprod Biomed</source>. <year>2018</year>;<volume>16</volume>(<issue>5</issue>):<fpage>323</fpage>&#x02010;<lpage>334</lpage>.<pub-id pub-id-type="pmid">30027148</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="ame212477-cit-0050">
<string-name>
<surname>Khedr</surname>
<given-names>NF</given-names>
</string-name>. <article-title>Protective effect of mirtazapine and hesperidin on cyclophosphamide&#x02010;induced oxidative damage and infertility in rat ovaries</article-title>. <source>Exp Biol Med (Maywood)</source>. <year>2015</year>;<volume>240</volume>(<issue>12</issue>):<fpage>1682</fpage>&#x02010;<lpage>1689</lpage>.<pub-id pub-id-type="pmid">25787947</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="ame212477-cit-0051">
<string-name>
<surname>Yener</surname>
<given-names>NA</given-names>
</string-name>, <string-name>
<surname>Sinanoglu</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Ilter</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>Effects of spirulina on cyclophosphamide&#x02010;induced ovarian toxicity in rats: biochemical and histomorphometric evaluation of the ovary</article-title>. <source>Biochem Res Int</source>. <year>2013</year>;<volume>2013</volume>:<elocation-id>764262</elocation-id>.<pub-id pub-id-type="pmid">23762559</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="ame212477-cit-0052">
<string-name>
<surname>Elsenosi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Aziza</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hussein</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mohsen</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Elnahas</surname>
<given-names>K</given-names>
</string-name>. <article-title>Curcumin and/or hesperidin alleviates oxidative stress and hormonal alterations in a rat model of cyclophosphamide&#x02010;induced premature ovarian failure</article-title>. <source>Benha Vet Med J</source>. <year>2020</year>;<volume>39</volume>:<fpage>95</fpage>&#x02010;<lpage>100</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="ame212477-cit-0053">
<string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>D</given-names>
</string-name>. <article-title>Niacin inhibits apoptosis and rescues premature ovarian failure</article-title>. <source>Cell Physiol Biochem</source>. <year>2018</year>;<volume>50</volume>(<issue>6</issue>):<fpage>2060</fpage>&#x02010;<lpage>2070</lpage>.<pub-id pub-id-type="pmid">30415247</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="ame212477-cit-0054">
<string-name>
<surname>Di Emidio</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rossi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Bonomo</surname>
<given-names>I</given-names>
</string-name>, et&#x000a0;al. <article-title>The natural carotenoid crocetin and the synthetic tellurium compound AS101 protect the ovary against cyclophosphamide by modulating SIRT1 and mitochondrial markers</article-title>. <source>Oxidative Med Cell Longev</source>. <year>2017</year>;<volume>2017</volume>:<elocation-id>8928604</elocation-id>.</mixed-citation></ref><ref id="ame212477-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="ame212477-cit-0055">
<string-name>
<surname>Salminen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kaarniranta</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kauppinen</surname>
<given-names>A</given-names>
</string-name>. <article-title>Crosstalk between oxidative stress and SIRT1: impact on the aging process</article-title>. <source>Int J Mol Sci</source>. <year>2013</year>;<volume>14</volume>(<issue>2</issue>):<fpage>3834</fpage>&#x02010;<lpage>3859</lpage>.<pub-id pub-id-type="pmid">23434668</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="ame212477-cit-0056">
<string-name>
<surname>Zhang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Nrf2 signaling pathway mediates the protective effects of daphnetin against D&#x02010;galactose induced&#x02010;premature ovarian failure</article-title>. <source>Front Pharmacol</source>. <year>2022</year>;<volume>13</volume>:<elocation-id>810524</elocation-id>.<pub-id pub-id-type="pmid">35153783</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="ame212477-cit-0057">
<string-name>
<surname>Ma</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>XY</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>XT</given-names>
</string-name>. <article-title>Melatonin protects premature ovarian insufficiency induced by tripterygium glycosides: role of SIRT1</article-title>. <source>Am J Transl Res</source>. <year>2017</year>;<volume>9</volume>(<issue>4</issue>):<fpage>1580</fpage>&#x02010;<lpage>1602</lpage>.<pub-id pub-id-type="pmid">28469767</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="ame212477-cit-0058">
<string-name>
<surname>Ma</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Xiao</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Enhanced cisplatin chemotherapy by iron oxide nanocarrier&#x02010;mediated generation of highly toxic reactive oxygen species</article-title>. <source>Nano Lett</source>. <year>2017</year>;<volume>17</volume>(<issue>2</issue>):<fpage>928</fpage>&#x02010;<lpage>937</lpage>.<pub-id pub-id-type="pmid">28139118</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="ame212477-cit-0059">
<string-name>
<surname>Wang</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Hutt</surname>
<given-names>KJ</given-names>
</string-name>. <article-title>Evaluation of mitochondria in mouse oocytes following cisplatin exposure</article-title>. <source>J Ovarian Res</source>. <year>2021</year>;<volume>14</volume>(<issue>1</issue>):<elocation-id>65</elocation-id>.<pub-id pub-id-type="pmid">33971923</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="ame212477-cit-0060">
<string-name>
<surname>Kelland</surname>
<given-names>L</given-names>
</string-name>. <article-title>The resurgence of platinum&#x02010;based cancer chemotherapy</article-title>. <source>Nat Rev Cancer</source>. <year>2007</year>;<volume>7</volume>:<fpage>573</fpage>&#x02010;<lpage>584</lpage>.<pub-id pub-id-type="pmid">17625587</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="ame212477-cit-0061">
<string-name>
<surname>Gonfloni</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tella</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Caldarola</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Inhibition of the c&#x02010;Abl&#x02010;TAp63 pathway protects mouse oocytes from chemotherapy&#x02010;induced death</article-title>. <source>Nat Med</source>. <year>2009</year>;<volume>15</volume>:<fpage>1179</fpage>&#x02010;<lpage>1185</lpage>.<pub-id pub-id-type="pmid">19783996</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="ame212477-cit-0062">
<string-name>
<surname>Kim</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Cordeiro</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Serna</surname>
<given-names>VA</given-names>
</string-name>, et&#x000a0;al. <article-title>Rescue of platinum&#x02010;damaged oocytes from programmed cell death through inactivation of the p53 family signaling network</article-title>. <source>Cell Death Dis</source>. <year>2013</year>;<volume>20</volume>(<issue>8</issue>):<fpage>987</fpage>&#x02010;<lpage>997</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="ame212477-cit-0063">
<string-name>
<surname>G&#x000fc;rsoy</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sade</surname>
<given-names>AG</given-names>
</string-name>. <article-title>Effects of diosmin administration on cisplatin&#x02010;induced premature ovarian failure in a rat model</article-title>. <source>J Contemp Med</source>. <year>2022</year>;<volume>12</volume>:<fpage>912</fpage>&#x02010;<lpage>916</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="ame212477-cit-0064">
<string-name>
<surname>Barberino</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Menezes</surname>
<given-names>VG</given-names>
</string-name>, <string-name>
<surname>Ribeiro</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Melatonin protects against cisplatin&#x02010;induced ovarian damage in mice via the MT1 receptor and antioxidant activity</article-title>. <source>Biol Reprod</source>. <year>2017</year>;<volume>96</volume>(<issue>6</issue>):<fpage>1244</fpage>&#x02010;<lpage>1255</lpage>.<pub-id pub-id-type="pmid">28595266</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="ame212477-cit-0065">
<string-name>
<surname>Damia</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Filiberti</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Vikhanskaya</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Cisplatinum and taxol induce different patterns of p53 phosphorylation</article-title>. <source>Neoplasia</source>. <year>2001</year>;<volume>3</volume>(<issue>1</issue>):<fpage>10</fpage>&#x02010;<lpage>16</lpage>.<pub-id pub-id-type="pmid">11326311</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="ame212477-cit-0066">
<string-name>
<surname>Tuppi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kehrloesser</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Coutandin</surname>
<given-names>DW</given-names>
</string-name>, et&#x000a0;al. <article-title>Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63</article-title>. <source>Nat Struct Mol Biol</source>. <year>2018</year>;<volume>25</volume>(<issue>3</issue>):<fpage>261</fpage>&#x02010;<lpage>269</lpage>.<pub-id pub-id-type="pmid">29483652</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="ame212477-cit-0067">
<string-name>
<surname>Chang</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Lim</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Yoon</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Cisplatin induces overactivation of the dormant primordial follicle through PTEN/AKT/FOXO3a pathway which leads to loss of ovarian reserve in mice</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>12</issue>):<elocation-id>e0144245</elocation-id>.<pub-id pub-id-type="pmid">26656301</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="ame212477-cit-0068">
<string-name>
<surname>Yucebilgin</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Terek</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Ozsaran</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility</article-title>. <source>Aust NZ J Obstet Gynaecol</source>. <year>2004</year>;<volume>44</volume>(<issue>1</issue>):<fpage>6</fpage>&#x02010;<lpage>9</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="ame212477-cit-0069">
<string-name>
<surname>Jang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Na</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>Synergistic effect of melatonin and ghrelin in preventing cisplatin&#x02010;induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27(Kip1) promoter in primordial follicles</article-title>. <source>J Pineal Res</source>. <year>2017</year>;<volume>63</volume>(<issue>3</issue>):<elocation-id>e12432</elocation-id>.</mixed-citation></ref><ref id="ame212477-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="ame212477-cit-0070">
<string-name>
<surname>Eldani</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Luan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Bargar</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>SY</given-names>
</string-name>. <article-title>Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation</article-title>. <source>FASEB J</source>. <year>2020</year>;<volume>34</volume>(<issue>10</issue>):<fpage>13885</fpage>&#x02010;<lpage>13899</lpage>.<pub-id pub-id-type="pmid">32830364</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="ame212477-cit-0071">
<string-name>
<surname>Altuner</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gulaboglu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yapca</surname>
<given-names>OE</given-names>
</string-name>, <string-name>
<surname>Cetin</surname>
<given-names>N</given-names>
</string-name>. <article-title>The effect of mirtazapine on cisplatin&#x02010;induced oxidative damage and infertility in rat ovaries</article-title>. <source>Sci World J</source>. <year>2013</year>;<volume>2013</volume>:<elocation-id>327240</elocation-id>.</mixed-citation></ref><ref id="ame212477-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="ame212477-cit-0072">
<string-name>
<surname>Morgan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lopes</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Gourley</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Spears</surname>
<given-names>N</given-names>
</string-name>. <article-title>Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>7</issue>):<elocation-id>e70117</elocation-id>.<pub-id pub-id-type="pmid">23922929</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="ame212477-cit-0073">
<string-name>
<surname>Rawat</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Jaiswal</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Khurana</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bhatti</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Navik</surname>
<given-names>U</given-names>
</string-name>. <article-title>Doxorubicin&#x02010;induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management</article-title>. <source>Biomed Pharmacother</source>. <year>2021</year>;<volume>139</volume>:<elocation-id>111708</elocation-id>.<pub-id pub-id-type="pmid">34243633</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="ame212477-cit-0074">
<string-name>
<surname>Renu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Pureti</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Vellingiri</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Valsala</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Toxic effects and molecular mechanism of doxorubicin on different organs &#x02013; an update</article-title>. <source>Toxin Rev</source>. <year>2022</year>;<volume>41</volume>(<issue>2</issue>):<fpage>650</fpage>&#x02010;<lpage>674</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="ame212477-cit-0075">
<string-name>
<surname>Tokarska&#x02010;Schlattner</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zaugg</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zuppinger</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wallimann</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Schlattner</surname>
<given-names>U</given-names>
</string-name>. <article-title>New insights into doxorubicin&#x02010;induced cardiotoxicity: the critical role of cellular energetics</article-title>. <source>J Mol Cell Cardiol</source>. <year>2006</year>;<volume>41</volume>(<issue>3</issue>):<fpage>389</fpage>&#x02010;<lpage>405</lpage>.<pub-id pub-id-type="pmid">16879835</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="ame212477-cit-0076">
<string-name>
<surname>Clementi</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Giardina</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Di Stasio</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mordente</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Misiti</surname>
<given-names>F</given-names>
</string-name>. <article-title>Doxorubicin&#x02010;derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria</article-title>. <source>Anticancer Res</source>. <year>2003</year>;<volume>23</volume>(<issue>3b</issue>):<fpage>2445</fpage>&#x02010;<lpage>2450</lpage>.<pub-id pub-id-type="pmid">12894526</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="ame212477-cit-0077">
<string-name>
<surname>Thorn</surname>
<given-names>CF</given-names>
</string-name>, <string-name>
<surname>Oshiro</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Marsh</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Doxorubicin pathways: pharmacodynamics and adverse effects</article-title>. <source>Pharmacogenet Genomics</source>. <year>2011</year>;<volume>21</volume>(<issue>7</issue>):<fpage>440</fpage>&#x02010;<lpage>446</lpage>.<pub-id pub-id-type="pmid">21048526</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="ame212477-cit-0078">
<string-name>
<surname>Xiao</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Iwahata</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Rogers</surname>
<given-names>HB</given-names>
</string-name>, <string-name>
<surname>Woodruff</surname>
<given-names>TK</given-names>
</string-name>. <article-title>Doxorubicin has dose&#x02010;dependent toxicity on mouse ovarian follicle development, hormone secretion, and oocyte maturation</article-title>. <source>Toxicol Sci</source>. <year>2017</year>;<volume>157</volume>(<issue>2</issue>):<fpage>320</fpage>&#x02010;<lpage>329</lpage>.<pub-id pub-id-type="pmid">28329872</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="ame212477-cit-0079">
<string-name>
<surname>Roti Roti</surname>
<given-names>EC</given-names>
</string-name>, <string-name>
<surname>Leisman</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Abbott</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Salih</surname>
<given-names>SM</given-names>
</string-name>. <article-title>Acute doxorubicin insult in the mouse ovary is cell&#x02010; and follicle&#x02010;type dependent</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>8</issue>):<elocation-id>e42293</elocation-id>.<pub-id pub-id-type="pmid">22876313</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="ame212477-cit-0080">
<string-name>
<surname>Perez</surname>
<given-names>GI</given-names>
</string-name>, <string-name>
<surname>Knudson</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Leykin</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Korsmeyer</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Tilly</surname>
<given-names>JL</given-names>
</string-name>. <article-title>Apoptosis&#x02010;associated signaling pathways are required for chemotherapy&#x02010;mediated female germ cell destruction</article-title>. <source>Nat Med</source>. <year>1997</year>;<volume>3</volume>(<issue>11</issue>):<fpage>1228</fpage>&#x02010;<lpage>1232</lpage>.<pub-id pub-id-type="pmid">9359697</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="ame212477-cit-0081">
<string-name>
<surname>Ben&#x02010;Aharon</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bar&#x02010;Joseph</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tzarfaty</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Doxorubicin&#x02010;induced ovarian toxicity</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2010</year>;<volume>8</volume>(<issue>1</issue>):<elocation-id>20</elocation-id>.<pub-id pub-id-type="pmid">20202194</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="ame212477-cit-0082">
<string-name>
<surname>Zhang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>HG</given-names>
</string-name>. <article-title>Effect of doxorubicin&#x02010;induced ovarian toxicity on mouse ovarian granulosa cells</article-title>. <source>Regul Toxicol Pharmacol</source>. <year>2017</year>;<volume>86</volume>:<fpage>1</fpage>&#x02010;<lpage>10</lpage>.<pub-id pub-id-type="pmid">28219713</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="ame212477-cit-0083">
<string-name>
<surname>Ben&#x02010;Aharon</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bar&#x02010;Yosef</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Rizel</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sulkes</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Stemmer</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Shalgi</surname>
<given-names>R</given-names>
</string-name>. <article-title>Doxorubicin induced apoptosis in oocytes&#x02014;mechanism and possible executers</article-title>. <source>J Clin Oncol</source>. <year>2008</year>;<volume>26</volume>(<issue>15_suppl</issue>):<elocation-id>9611</elocation-id>.</mixed-citation></ref><ref id="ame212477-bib-0084"><label>84</label><mixed-citation publication-type="book" id="ame212477-cit-0084">
<string-name>
<surname>Patel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Tadi</surname>
<given-names>P</given-names>
</string-name>. <source>Busulfan</source>. <publisher-name>StatPearls Publishing</publisher-name>; <year>2023</year>. Accessed <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK555986/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK555986/</ext-link>
</mixed-citation></ref><ref id="ame212477-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="ame212477-cit-0085">
<string-name>
<surname>Chen</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Protective effects of puerarin on premature ovarian failure via regulation of Wnt/&#x003b2;&#x02010;catenin signaling pathway and oxidative stress</article-title>. <source>Reprod Sci</source>. <year>2021</year>;<volume>28</volume>(<issue>4</issue>):<fpage>982</fpage>&#x02010;<lpage>990</lpage>.<pub-id pub-id-type="pmid">32996063</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="ame212477-cit-0086">
<string-name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Qi</surname>
<given-names>HJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Accelerated ovarian aging in mice by treatment of busulfan and cyclophosphamide</article-title>. <source>J Zhejiang Univ Sci B</source>. <year>2013</year>;<volume>14</volume>(<issue>4</issue>):<fpage>318</fpage>&#x02010;<lpage>324</lpage>.<pub-id pub-id-type="pmid">23549849</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="ame212477-cit-0087">
<string-name>
<surname>Liu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Qiu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xue</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Small extracellular vesicles derived from embryonic stem cells restore ovarian function of premature ovarian failure through PI3K/AKT signaling pathway</article-title>. <source>Stem Cell Res Ther</source>. <year>2020</year>;<volume>11</volume>(<issue>1</issue>):<elocation-id>3</elocation-id>.<pub-id pub-id-type="pmid">31900201</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="ame212477-cit-0088">
<string-name>
<surname>Luo</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Yin</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, et&#x000a0;al. <article-title>Role of SDF&#x02010;1/CXCR4 and cytokines in the development of ovary injury in chemotherapy drug induced premature ovarian failure mice</article-title>. <source>Life Sci</source>. <year>2017</year>;<volume>179</volume>:<fpage>103</fpage>&#x02010;<lpage>109</lpage>.<pub-id pub-id-type="pmid">28478265</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="ame212477-cit-0089">
<string-name>
<surname>Lee</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Han</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>MJ</given-names>
</string-name>, et&#x000a0;al. <article-title>Establishment of effective mouse model of premature ovarian failure considering treatment duration of anticancer drugs and natural recovery time</article-title>. <source>J Menopausal Med</source>. <year>2018</year>;<volume>24</volume>(<issue>3</issue>):<fpage>196</fpage>&#x02010;<lpage>203</lpage>.<pub-id pub-id-type="pmid">30671413</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="ame212477-cit-0090">
<string-name>
<surname>Bahrehbar</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Rezazadeh Valojerdi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Esfandiari</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Fathi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Hassani</surname>
<given-names>SN</given-names>
</string-name>, <string-name>
<surname>Baharvand</surname>
<given-names>H</given-names>
</string-name>. <article-title>Human embryonic stem cell&#x02010;derived mesenchymal stem cells improved premature ovarian failure</article-title>. <source>World J Stem Cells</source>. <year>2020</year>;<volume>12</volume>(<issue>8</issue>):<fpage>857</fpage>&#x02010;<lpage>878</lpage>.<pub-id pub-id-type="pmid">32952863</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="ame212477-cit-0091">
<string-name>
<surname>Mahran</surname>
<given-names>YF</given-names>
</string-name>, <string-name>
<surname>El&#x02010;Demerdash</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Nada</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>El&#x02010;Naga</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Ali</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Abdel&#x02010;Naim</surname>
<given-names>AB</given-names>
</string-name>. <article-title>Growth hormone ameliorates the radiotherapy&#x02010;induced ovarian follicular loss in rats: impact on oxidative stress, apoptosis and IGF&#x02010;1/IGF&#x02010;1R Axis</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>10</issue>):<elocation-id>e0140055</elocation-id>.<pub-id pub-id-type="pmid">26465611</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="ame212477-cit-0092">
<string-name>
<surname>Constine</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Woolf</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Cann</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Hypothalamic&#x02013;pituitary dysfunction after radiation for brain tumors</article-title>. <source>N Engl J Med</source>. <year>1993</year>;<volume>328</volume>(<issue>2</issue>):<fpage>87</fpage>&#x02010;<lpage>94</lpage>.<pub-id pub-id-type="pmid">8416438</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="ame212477-cit-0093">
<string-name>
<surname>Gosden</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Wade</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Fraser</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Sandow</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Faddy</surname>
<given-names>MJ</given-names>
</string-name>. <article-title>Impact of congenital or experimental hypogonadotrophism on the radiation sensitivity of the mouse ovary</article-title>. <source>Hum Reprod</source>. <year>1997</year>;<volume>12</volume>(<issue>11</issue>):<fpage>2483</fpage>&#x02010;<lpage>2488</lpage>.<pub-id pub-id-type="pmid">9436690</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="ame212477-cit-0094">
<string-name>
<surname>Simon</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Partridge</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Runowicz</surname>
<given-names>CD</given-names>
</string-name>. <article-title>Preserving fertility after cancer</article-title>. <source>CA Cancer J Clin</source>. <year>2005</year>;<volume>55</volume>(<issue>4</issue>):<fpage>211</fpage>&#x02010;<lpage>228</lpage>; quiz 63&#x02013;4.<pub-id pub-id-type="pmid">16020423</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="ame212477-cit-0095">
<string-name>
<surname>Martin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lefaix</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Delanian</surname>
<given-names>S</given-names>
</string-name>. <article-title>TGF&#x02010;beta1 and radiation fibrosis: a master switch and a specific therapeutic target?</article-title>
<source>Int J Radiat Oncol Biol Phys</source>. <year>2000</year>;<volume>47</volume>(<issue>2</issue>):<fpage>277</fpage>&#x02010;<lpage>290</lpage>.<pub-id pub-id-type="pmid">10802350</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="ame212477-cit-0096">
<string-name>
<surname>Hosseinimehr</surname>
<given-names>SJ</given-names>
</string-name>. <article-title>The use of angiotensin II receptor antagonists to increase the efficacy of radiotherapy in cancer treatment</article-title>. <source>Future Oncol</source>. <year>2014</year>;<volume>10</volume>(<issue>15</issue>):<fpage>2381</fpage>&#x02010;<lpage>2390</lpage>.<pub-id pub-id-type="pmid">25525846</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="ame212477-cit-0097">
<string-name>
<surname>Cai</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zong</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Tong</surname>
<given-names>GQ</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>. <article-title>Apoptotic mechanism of premature ovarian failure and rescue effect of traditional Chinese medicine: a review</article-title>. <source>J Tradit Chin Med</source>. <year>2021</year>;<volume>41</volume>(<issue>3</issue>):<fpage>492</fpage>&#x02010;<lpage>498</lpage>.<pub-id pub-id-type="pmid">34114409</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="ame212477-cit-0098">
<string-name>
<surname>Kerr</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Brogan</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Myers</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>The primordial follicle reserve is not renewed after chemical or &#x003b3;&#x02010;irradiation mediated depletion</article-title>. <source>Reproduction</source>. <year>2012</year>;<volume>143</volume>(<issue>4</issue>):<fpage>469</fpage>&#x02010;<lpage>476</lpage>.<pub-id pub-id-type="pmid">22301887</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0099"><label>99</label><mixed-citation publication-type="journal" id="ame212477-cit-0099">
<string-name>
<surname>Kim</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Seo</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Cellular stress responses in radiotherapy</article-title>. <source>Cells</source>. <year>2019</year>;<volume>8</volume>(<issue>9</issue>):<fpage>1105</fpage>.<pub-id pub-id-type="pmid">31540530</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="ame212477-cit-0100">
<string-name>
<surname>Hirao</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cheung</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Duncan</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)&#x02010;dependent and an ATM&#x02010;independent manner</article-title>. <source>Mol Cell Biol</source>. <year>2002</year>;<volume>22</volume>(<issue>18</issue>):<fpage>6521</fpage>&#x02010;<lpage>6532</lpage>.<pub-id pub-id-type="pmid">12192050</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="ame212477-cit-0101">
<string-name>
<surname>Wallace</surname>
<given-names>WHB</given-names>
</string-name>, <string-name>
<surname>Thomson</surname>
<given-names>AB</given-names>
</string-name>, <string-name>
<surname>Kelsey</surname>
<given-names>TW</given-names>
</string-name>. <article-title>The radiosensitivity of the human oocyte</article-title>. <source>Hum Reprod Open</source>. <year>2003</year>;<volume>18</volume>(<issue>1</issue>):<fpage>117</fpage>&#x02010;<lpage>121</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="ame212477-cit-0102">
<string-name>
<surname>Mahran</surname>
<given-names>YF</given-names>
</string-name>, <string-name>
<surname>Badr</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Aldosari</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bin&#x02010;Zaid</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Alotaibi</surname>
<given-names>HN</given-names>
</string-name>. <article-title>Carvacrol and Thymol modulate the cross&#x02010;talk between TNF&#x02010; <italic toggle="yes">&#x003b1;</italic>and IGF&#x02010;1 signaling in radiotherapy&#x02010;induced ovarian failure</article-title>. <source>Oxidative Med Cell Longev</source>. <year>2019</year>;<volume>2019</volume>:<elocation-id>3173745</elocation-id>.</mixed-citation></ref><ref id="ame212477-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="ame212477-cit-0103">
<string-name>
<surname>Mantawy</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Said</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Abdel&#x02010;Aziz</surname>
<given-names>AK</given-names>
</string-name>. <article-title>Mechanistic approach of the inhibitory effect of chrysin on inflammatory and apoptotic events implicated in radiation&#x02010;induced premature ovarian failure: emphasis on TGF&#x02010;&#x003b2;/MAPKs signaling pathway</article-title>. <source>Biomed Pharmacother</source>. <year>2019</year>;<volume>109</volume>:<fpage>293</fpage>&#x02010;<lpage>303</lpage>.<pub-id pub-id-type="pmid">30396087</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="ame212477-cit-0104">
<string-name>
<surname>Chapman</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Cree</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Shelling</surname>
<given-names>AN</given-names>
</string-name>. <article-title>The genetics of premature ovarian failure: current perspectives</article-title>. <source>Int J Women's Health</source>. <year>2015</year>;<volume>7</volume>:<fpage>799</fpage>&#x02010;<lpage>810</lpage>.<pub-id pub-id-type="pmid">26445561</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="ame212477-cit-0105">
<string-name>
<surname>Dixit</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Rao</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Padmalatha</surname>
<given-names>V</given-names>
</string-name>, et&#x000a0;al. <article-title>Genes governing premature ovarian failure</article-title>. <source>Reprod Biomed Online</source>. <year>2010</year>;<volume>20</volume>(<issue>6</issue>):<fpage>724</fpage>&#x02010;<lpage>740</lpage>.<pub-id pub-id-type="pmid">20382564</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="ame212477-cit-0106">
<string-name>
<surname>Shelling</surname>
<given-names>AN</given-names>
</string-name>, <string-name>
<surname>Burton</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Chand</surname>
<given-names>AL</given-names>
</string-name>, et&#x000a0;al. <article-title>Inhibin: a candidate gene for premature ovarian failure</article-title>. <source>Hum Reprod</source>. <year>2000</year>;<volume>15</volume>(<issue>12</issue>):<fpage>2644</fpage>&#x02010;<lpage>2649</lpage>.<pub-id pub-id-type="pmid">11098038</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="ame212477-cit-0107">
<string-name>
<surname>Goswami</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Conway</surname>
<given-names>GS</given-names>
</string-name>. <article-title>Premature ovarian failure</article-title>. <source>Hum Reprod</source>. <year>2005</year>;<volume>11</volume>(<issue>4</issue>):<fpage>391</fpage>&#x02010;<lpage>410</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="ame212477-cit-0108">
<string-name>
<surname>Chen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>. <article-title>Selected genetic factors associated with primary ovarian insufficiency</article-title>. <source>Int J Mol Sci</source>. <year>2023</year>;<volume>24</volume>(<issue>5</issue>):<fpage>4423</fpage>.<pub-id pub-id-type="pmid">36901862</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="ame212477-cit-0109">
<string-name>
<surname>Jagarlamudi</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Reddy</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Adhikari</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>K</given-names>
</string-name>. <article-title>Genetically modified mouse models for premature ovarian failure (POF)</article-title>. <source>Mol Cell Endocrinol</source>. <year>2010</year>;<volume>315</volume>(<issue>1&#x02013;2</issue>):<fpage>1</fpage>&#x02010;<lpage>10</lpage>.<pub-id pub-id-type="pmid">19643165</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="ame212477-cit-0110">
<string-name>
<surname>Yamada</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hinch</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Kamido</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Edelmann</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Keeney</surname>
<given-names>S</given-names>
</string-name>. <article-title>Molecular structures and mechanisms of DNA break processing in mouse meiosis</article-title>. <source>Genes Dev</source>. <year>2020</year>;<volume>34</volume>(<issue>11&#x02013;12</issue>):<fpage>806</fpage>&#x02010;<lpage>818</lpage>.<pub-id pub-id-type="pmid">32354835</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="ame212477-cit-0111">
<string-name>
<surname>Keeney</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Giroux</surname>
<given-names>CN</given-names>
</string-name>, <string-name>
<surname>Kleckner</surname>
<given-names>N</given-names>
</string-name>. <article-title>Meiosis&#x02010;specific DNA double&#x02010;strand breaks are catalyzed by Spo11, a member of a widely conserved protein family</article-title>. <source>Cell</source>. <year>1997</year>;<volume>88</volume>(<issue>3</issue>):<fpage>375</fpage>&#x02010;<lpage>384</lpage>.<pub-id pub-id-type="pmid">9039264</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="ame212477-cit-0112">
<string-name>
<surname>Romanienko</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Camerini&#x02010;Otero</surname>
<given-names>RD</given-names>
</string-name>. <article-title>The mouse Spo11 gene is required for meiotic chromosome synapsis</article-title>. <source>Mol Cell</source>. <year>2000</year>;<volume>6</volume>(<issue>5</issue>):<fpage>975</fpage>&#x02010;<lpage>987</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="ame212477-cit-0113">
<string-name>
<surname>de Vries</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Baart</surname>
<given-names>EB</given-names>
</string-name>, <string-name>
<surname>Dekker</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Mouse MutS&#x02010;like protein Msh5 is required for proper chromosome synapsis in male and female meiosis</article-title>. <source>Genes Dev</source>. <year>1999</year>;<volume>13</volume>(<issue>5</issue>):<fpage>523</fpage>&#x02010;<lpage>531</lpage>.<pub-id pub-id-type="pmid">10072381</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="ame212477-cit-0114">
<string-name>
<surname>Harris</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Chand</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Winship</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Gersak</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Aittom&#x000e4;ki</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Shelling</surname>
<given-names>AN</given-names>
</string-name>. <article-title>Identification of novel mutations in FOXL2 associated with premature ovarian failure</article-title>. <source>Mol Hum Reprod</source>. <year>2002</year>;<volume>8</volume>(<issue>8</issue>):<fpage>729</fpage>&#x02010;<lpage>733</lpage>.<pub-id pub-id-type="pmid">12149404</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="ame212477-cit-0115">
<string-name>
<surname>Schmidt</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ovitt</surname>
<given-names>CE</given-names>
</string-name>, <string-name>
<surname>Anlag</surname>
<given-names>K</given-names>
</string-name>, et&#x000a0;al. <article-title>The murine winged&#x02010;helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance</article-title>. <source>Development</source>. <year>2004</year>;<volume>131</volume>(<issue>4</issue>):<fpage>933</fpage>&#x02010;<lpage>942</lpage>.<pub-id pub-id-type="pmid">14736745</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="ame212477-cit-0116">
<string-name>
<surname>Rajkovic</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Pangas</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Ballow</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Suzumori</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Matzuk</surname>
<given-names>MM</given-names>
</string-name>. <article-title>NOBOX deficiency disrupts early folliculogenesis and oocyte&#x02010;specific gene expression</article-title>. <source>Science</source>. <year>2004</year>;<volume>305</volume>(<issue>5687</issue>):<fpage>1157</fpage>&#x02010;<lpage>1159</lpage>.<pub-id pub-id-type="pmid">15326356</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="ame212477-cit-0117">
<string-name>
<surname>Soyal</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Amleh</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dean</surname>
<given-names>J</given-names>
</string-name>. <article-title>FIGalpha, a germ cell&#x02010;specific transcription factor required for ovarian follicle formation</article-title>. <source>Development</source>. <year>2000</year>;<volume>127</volume>(<issue>21</issue>):<fpage>4645</fpage>&#x02010;<lpage>4654</lpage>.<pub-id pub-id-type="pmid">11023867</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="ame212477-cit-0118">
<string-name>
<surname>Ghadami</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>El&#x02010;Demerdash</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>D</given-names>
</string-name>, et&#x000a0;al. <article-title>Bone marrow transplantation restores follicular maturation and steroid hormones production in a mouse model for primary ovarian failure</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>3</issue>):<elocation-id>e32462</elocation-id>.<pub-id pub-id-type="pmid">22412875</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="ame212477-cit-0119">
<string-name>
<surname>Danilovich</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Babu</surname>
<given-names>PS</given-names>
</string-name>, <string-name>
<surname>Xing</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Gerdes</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Krishnamurthy</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sairam</surname>
<given-names>MR</given-names>
</string-name>. <article-title>Estrogen deficiency, obesity, and skeletal abnormalities in follicle&#x02010;stimulating hormone receptor knockout (FORKO) female mice</article-title>. <source>Endocrinology</source>. <year>2000</year>;<volume>141</volume>(<issue>11</issue>):<fpage>4295</fpage>&#x02010;<lpage>4308</lpage>.<pub-id pub-id-type="pmid">11089565</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="ame212477-cit-0120">
<string-name>
<surname>Lawson</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Dunn</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Roelen</surname>
<given-names>BA</given-names>
</string-name>, et&#x000a0;al. <article-title>Bmp4 is required for the generation of primordial germ cells in the mouse embryo</article-title>. <source>Genes Dev</source>. <year>1999</year>;<volume>13</volume>(<issue>4</issue>):<fpage>424</fpage>&#x02010;<lpage>436</lpage>.<pub-id pub-id-type="pmid">10049358</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="ame212477-cit-0121">
<string-name>
<surname>Ying</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>GQ</given-names>
</string-name>. <article-title>Cooperation of endoderm&#x02010;derived BMP2 and extraembryonic ectoderm&#x02010;derived BMP4 in primordial germ cell generation in the mouse</article-title>. <source>Dev Biol</source>. <year>2001</year>;<volume>232</volume>(<issue>2</issue>):<fpage>484</fpage>&#x02010;<lpage>492</lpage>.<pub-id pub-id-type="pmid">11401407</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="ame212477-cit-0122">
<string-name>
<surname>Tung</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Rosen</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Nelson</surname>
<given-names>LM</given-names>
</string-name>, et&#x000a0;al. <article-title>Novel missense mutations of the deleted&#x02010;in&#x02010;AZoospermia&#x02010;like (DAZL) gene in infertile women and men</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2006</year>;<volume>4</volume>:<elocation-id>40</elocation-id>.<pub-id pub-id-type="pmid">16884537</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="ame212477-cit-0123">
<string-name>
<surname>Ruggiu</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Speed</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Taggart</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis</article-title>. <source>Nature</source>. <year>1997</year>;<volume>389</volume>(<issue>6646</issue>):<fpage>73</fpage>&#x02010;<lpage>77</lpage>.<pub-id pub-id-type="pmid">9288969</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="ame212477-cit-0124">
<string-name>
<surname>Tsuda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sasaoka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kiso</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>Conserved role of nanos proteins in germ cell development</article-title>. <source>Science</source>. <year>2003</year>;<volume>301</volume>(<issue>5637</issue>):<fpage>1239</fpage>&#x02010;<lpage>1241</lpage>.<pub-id pub-id-type="pmid">12947200</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="ame212477-cit-0125">
<string-name>
<surname>Cheng</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Altmeppen</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>So</surname>
<given-names>C</given-names>
</string-name>, et&#x000a0;al. <article-title>Mammalian oocytes store mRNAs in a mitochondria&#x02010;associated membraneless compartment</article-title>. <source>Science</source>. <year>2022</year>;<volume>378</volume>(<issue>6617</issue>):<elocation-id>eabq4835</elocation-id>.<pub-id pub-id-type="pmid">36264786</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="ame212477-cit-0126">
<string-name>
<surname>Shang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>X</given-names>
</string-name>, et&#x000a0;al. <article-title>EIF4ENIF1 variants in two patients with non&#x02010;syndromic premature ovarian insufficiency</article-title>. <source>Eur J Med Genet</source>. <year>2022</year>;<volume>65</volume>(<issue>10</issue>):<elocation-id>104597</elocation-id>.<pub-id pub-id-type="pmid">36030004</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="ame212477-cit-0127">
<string-name>
<surname>Ding</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sha</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kee</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>L</given-names>
</string-name>. <article-title>Eif4enif1 haploinsufficiency disrupts oocyte mitochondrial dynamics and leads to subfertility</article-title>. <source>Development</source>. <year>2023</year>;<volume>150</volume>(<issue>23</issue>):<fpage>dev202151</fpage>.<pub-id pub-id-type="pmid">38088064</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="ame212477-cit-0128">
<string-name>
<surname>Huhtaniemi</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Hovatta</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>La Marca</surname>
<given-names>A</given-names>
</string-name>, et&#x000a0;al. <article-title>Advances in the molecular pathophysiology, genetics, and treatment of primary ovarian insufficiency</article-title>. <source>Trends Endocrinol Metab</source>. <year>2018</year>;<volume>29</volume>(<issue>6</issue>):<fpage>400</fpage>&#x02010;<lpage>419</lpage>.<pub-id pub-id-type="pmid">29706485</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0129"><label>129</label><mixed-citation publication-type="journal" id="ame212477-cit-0129">
<string-name>
<surname>Xu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Xia</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Qin</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Effects of low intensity pulsed ultrasound on expression of B&#x02010;cell lymphoma&#x02010;2 and BCL2&#x02010;associated X in premature ovarian failure mice induced by 4&#x02010;vinylcyclohexene diepoxide</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2021</year>;<volume>19</volume>(<issue>1</issue>):<elocation-id>113</elocation-id>.<pub-id pub-id-type="pmid">34284777</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0130"><label>130</label><mixed-citation publication-type="journal" id="ame212477-cit-0130">
<string-name>
<surname>Biswas</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tyc</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>El Yakoubi</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Morgan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Xing</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Schindler</surname>
<given-names>K</given-names>
</string-name>. <article-title>Meiosis interrupted: the genetics of female infertility via meiotic failure</article-title>. <source>Reproduction</source>. <year>2021</year>;<volume>161</volume>(<issue>2</issue>):<fpage>R13</fpage>&#x02010;<lpage>R35</lpage>.<pub-id pub-id-type="pmid">33170803</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="ame212477-cit-0131">
<string-name>
<surname>Yuan</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>He</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Bi&#x02010;allelic recessive loss&#x02010;of&#x02010;function mutations in FIGLA cause premature ovarian insufficiency with short stature</article-title>. <source>Clin Genet</source>. <year>2019</year>;<volume>95</volume>(<issue>3</issue>):<fpage>409</fpage>&#x02010;<lpage>414</lpage>.<pub-id pub-id-type="pmid">30474133</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="ame212477-cit-0132">
<string-name>
<surname>Zari&#x000f1;&#x000e1;n</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mayorga</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jard&#x000f3;n&#x02010;Valadez</surname>
<given-names>E</given-names>
</string-name>, et&#x000a0;al. <article-title>A novel mutation in the FSH receptor (I423T) affecting receptor activation and leading to primary ovarian failure</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2021</year>;<volume>106</volume>(<issue>2</issue>):<fpage>e534</fpage>&#x02010;<lpage>e550</lpage>.<pub-id pub-id-type="pmid">33119067</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="ame212477-cit-0133">
<string-name>
<surname>Rostami Dovom</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Noroozzadeh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mosaffa</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zadeh&#x02010;Vakili</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Piryaei</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ramezani</surname>
<given-names>TF</given-names>
</string-name>. <article-title>Induced premature ovarian insufficiency by using D galactose and its effects on reproductive profiles in small laboratory animals: a systematic review</article-title>. <source>J Ovarian Res</source>. <year>2019</year>;<volume>12</volume>(<issue>1</issue>):<elocation-id>96</elocation-id>.<pub-id pub-id-type="pmid">31619267</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="ame212477-cit-0134">
<string-name>
<surname>Chen</surname>
<given-names>YT</given-names>
</string-name>, <string-name>
<surname>Mattison</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Feigenbaum</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Fukui</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Schulman</surname>
<given-names>JD</given-names>
</string-name>. <article-title>Reduction in oocyte number following prenatal exposure to a diet high in galactose</article-title>. <source>Science</source>. <year>1981</year>;<volume>214</volume>(<issue>4525</issue>):<fpage>1145</fpage>&#x02010;<lpage>1147</lpage>.<pub-id pub-id-type="pmid">7302587</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="ame212477-cit-0135">
<string-name>
<surname>Li</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Icariin exerts a protective effect against d&#x02010;galactose induced premature ovarian failure via promoting DNA damage repair</article-title>. <source>Biomed Pharmacother</source>. <year>2019</year>;<volume>118</volume>:<elocation-id>109218</elocation-id>.<pub-id pub-id-type="pmid">31330441</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="ame212477-cit-0136">
<string-name>
<surname>Yan</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Curcumin exerts a protective effect against premature ovarian failure in mice</article-title>. <source>J Mol Endocrinol</source>. <year>2018</year>;<volume>60</volume>(<issue>3</issue>):<fpage>261</fpage>&#x02010;<lpage>271</lpage>.<pub-id pub-id-type="pmid">29437881</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="ame212477-cit-0137">
<string-name>
<surname>Shang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>. <article-title>Red ginseng improves D&#x02010;galactose&#x02010;induced premature ovarian failure in mice based on network pharmacology</article-title>. <source>Int J Mol Sci</source>. <year>2023</year>;<volume>24</volume>(<issue>9</issue>):<fpage>8210</fpage>.<pub-id pub-id-type="pmid">37175917</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="ame212477-cit-0138">
<string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>L</given-names>
</string-name>. <article-title>Chrysin reduces inflammation and oxidative stress and improves ovarian function in D&#x02010;gal&#x02010;induced premature ovarian failure</article-title>. <source>Bioengineered</source>. <year>2022</year>;<volume>13</volume>(<issue>4</issue>):<fpage>8291</fpage>&#x02010;<lpage>8301</lpage>.<pub-id pub-id-type="pmid">35311454</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="ame212477-cit-0139">
<string-name>
<surname>Lai</surname>
<given-names>KW</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>LY</given-names>
</string-name>, <string-name>
<surname>Cheung</surname>
<given-names>AL</given-names>
</string-name>, O WS. <article-title>Inhibitor of apoptosis proteins and ovarian dysfunction in galactosemic rats</article-title>. <source>Cell Tissue Res</source>. <year>2003</year>;<volume>311</volume>(<issue>3</issue>):<fpage>417</fpage>&#x02010;<lpage>425</lpage>.<pub-id pub-id-type="pmid">12658449</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="ame212477-cit-0140">
<string-name>
<surname>Dai</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Comparison of the different animal modeling and therapy methods of premature ovarian failure in animal model</article-title>. <source>Stem Cell Res Ther</source>. <year>2023</year>;<volume>14</volume>(<issue>1</issue>):<elocation-id>135</elocation-id>.<pub-id pub-id-type="pmid">37202808</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="ame212477-cit-0141">
<string-name>
<surname>Claes</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ball</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Scoggin</surname>
<given-names>KE</given-names>
</string-name>, et&#x000a0;al. <article-title>The interrelationship between anti&#x02010;M&#x000fc;llerian hormone, ovarian follicular populations and age in mares</article-title>. <source>Equine Vet J</source>. <year>2015</year>;<volume>47</volume>(<issue>5</issue>):<fpage>537</fpage>&#x02010;<lpage>541</lpage>.<pub-id pub-id-type="pmid">25124401</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="ame212477-cit-0142">
<string-name>
<surname>Nelson</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Telfer</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>RA</given-names>
</string-name>. <article-title>The ageing ovary and uterus: new biological insights</article-title>. <source>Hum Reprod</source>. <year>2013</year>;<volume>19</volume>(<issue>1</issue>):<fpage>67</fpage>&#x02010;<lpage>83</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="ame212477-cit-0143">
<string-name>
<surname>Rah</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jeon</surname>
<given-names>YJ</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>WS</given-names>
</string-name>, et&#x000a0;al. <article-title>Association of nitric oxide synthase gene polymorphisms (&#x02212;786T&#x0003e;C, 4a4b, 894G&#x0003e;T) with primary ovarian insufficiency in Korean women</article-title>. <source>Maturitas</source>. <year>2013</year>;<volume>74</volume>(<issue>2</issue>):<fpage>160</fpage>&#x02010;<lpage>165</lpage>.<pub-id pub-id-type="pmid">23176758</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="ame212477-cit-0144">
<string-name>
<surname>Wu</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Liang</surname>
<given-names>CY</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>TT</given-names>
</string-name>, et&#x000a0;al. <article-title>Protective roles and mechanisms of polysaccharides from dendrobium officinal on natural aging&#x02010;induced premature ovarian failure</article-title>. <source>Biomed Pharmacother</source>. <year>2018</year>;<volume>101</volume>:<fpage>953</fpage>&#x02010;<lpage>960</lpage>.<pub-id pub-id-type="pmid">29635905</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="ame212477-cit-0145">
<string-name>
<surname>Ding</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zou</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>F</given-names>
</string-name>, et&#x000a0;al. <article-title>Human amniotic mesenchymal stem cells improve ovarian function in natural aging through secreting hepatocyte growth factor and epidermal growth factor</article-title>. <source>Stem Cell Res Ther</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<elocation-id>55</elocation-id>.<pub-id pub-id-type="pmid">29523193</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="ame212477-cit-0146">
<string-name>
<surname>Qin</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>T</given-names>
</string-name>, et&#x000a0;al. <article-title>TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide&#x02010;induced premature ovarian failure model mice</article-title>. <source>Nat Commun</source>. <year>2022</year>;<volume>13</volume>(<issue>1</issue>):<elocation-id>914</elocation-id>.<pub-id pub-id-type="pmid">35177657</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="ame212477-cit-0147">
<string-name>
<surname>Nie</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Dai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>Establishment of a mouse model of premature ovarian failure using consecutive superovulation</article-title>. <source>Cell Physiol Biochem</source>. <year>2018</year>;<volume>51</volume>(<issue>5</issue>):<fpage>2341</fpage>&#x02010;<lpage>2358</lpage>.<pub-id pub-id-type="pmid">30537739</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="ame212477-cit-0148">
<string-name>
<surname>Tavana</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Valojerdi</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Azarnia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Shahverdi</surname>
<given-names>A</given-names>
</string-name>. <article-title>Restoration of ovarian tissue function and estrous cycle in rat after autotransplantation using hyaluronic acid hydrogel scaffold containing VEGF and bFGF</article-title>. <source>Growth Factors</source>. <year>2016</year>;<volume>34</volume>(<issue>3&#x02013;4</issue>):<fpage>97</fpage>&#x02010;<lpage>106</lpage>.<pub-id pub-id-type="pmid">27362476</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="ame212477-cit-0149">
<string-name>
<surname>Saber</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Eimani</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Soleimani Mehranjani</surname>
<given-names>M</given-names>
</string-name>, et&#x000a0;al. <article-title>The effect of verapamil on ischaemia/reperfusion injury in mouse ovarian tissue transplantation</article-title>. <source>Biomed Pharmacother</source>. <year>2018</year>;<volume>108</volume>:<fpage>1313</fpage>&#x02010;<lpage>1319</lpage>.<pub-id pub-id-type="pmid">30372833</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="ame212477-cit-0150">
<string-name>
<surname>Tavana</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Azarnia</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Valojerdi</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Shahverdi</surname>
<given-names>A</given-names>
</string-name>. <article-title>Hyaluronic acid&#x02010;based hydrogel scaffold without angiogenic growth factors enhances ovarian tissue function after autotransplantation in rats</article-title>. <source>Biomed Mater</source>. <year>2016</year>;<volume>11</volume>(<issue>5</issue>):<elocation-id>055006</elocation-id>.<pub-id pub-id-type="pmid">27710922</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="ame212477-cit-0151">
<string-name>
<surname>Lozada</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bhagavath</surname>
<given-names>B</given-names>
</string-name>. <article-title>A review of laparoscopic salpingo&#x02010;oophorectomy: technique and perioperative considerations</article-title>. <source>J Minim Invasive Gynecol</source>. <year>2017</year>;<volume>24</volume>(<issue>3</issue>):<fpage>364</fpage>&#x02010;<lpage>370</lpage>.<pub-id pub-id-type="pmid">28027976</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="ame212477-cit-0152">
<string-name>
<surname>Seok</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Lim</surname>
<given-names>J&#x02010;Y</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>KG</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>GJ</given-names>
</string-name>. <article-title>Placenta&#x02010;derived mesenchymal stem cells restore the ovary function in an ovariectomized rat model via an antioxidant effect</article-title>. <source>Antioxidants</source>. <year>2020</year>;<volume>9</volume>(<issue>7</issue>):<elocation-id>591</elocation-id>.<pub-id pub-id-type="pmid">32640638</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="ame212477-cit-0153">
<string-name>
<surname>Sen Halicioglu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Kasm</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mi</surname>
<given-names>T</given-names>
</string-name>. <article-title>The relationship of 4&#x02010;vinylcyclohexene diepoxide toxicity with cell death, oxidative stress, and gap junctions in female rat ovaries</article-title>. <source>Reprod Med Biol</source>. <year>2021</year>;<volume>20</volume>(<issue>4</issue>):<fpage>543</fpage>&#x02010;<lpage>553</lpage>.<pub-id pub-id-type="pmid">34646083</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="ame212477-cit-0154">
<string-name>
<surname>Nelson</surname>
<given-names>LM</given-names>
</string-name>. <article-title>Clinical practice. Primary ovarian insufficiency</article-title>. <source>N Engl J Med</source>. <year>2009</year>;<volume>360</volume>(<issue>6</issue>):<fpage>606</fpage>&#x02010;<lpage>614</lpage>.<pub-id pub-id-type="pmid">19196677</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="ame212477-cit-0155">
<string-name>
<surname>Devine</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Sipes</surname>
<given-names>IG</given-names>
</string-name>, <string-name>
<surname>Hoyer</surname>
<given-names>PB</given-names>
</string-name>. <article-title>Effect of 4&#x02010;vinylcyclohexene diepoxide dosing in rats on GSH levels in liver and ovaries</article-title>. <source>Toxicol Sci</source>. <year>2001</year>;<volume>62</volume>(<issue>2</issue>):<fpage>315</fpage>&#x02010;<lpage>320</lpage>.<pub-id pub-id-type="pmid">11452144</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0156"><label>156</label><mixed-citation publication-type="journal" id="ame212477-cit-0156">
<string-name>
<surname>Takai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Canning</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Perez</surname>
<given-names>GI</given-names>
</string-name>, et&#x000a0;al. <article-title>Bax, caspase&#x02010;2, and caspase&#x02010;3 are required for ovarian follicle loss caused by 4&#x02010;vinylcyclohexene diepoxide exposure of female mice in&#x000a0;vivo</article-title>. <source>Endocrinology</source>. <year>2003</year>;<volume>144</volume>(<issue>1</issue>):<fpage>69</fpage>&#x02010;<lpage>74</lpage>.<pub-id pub-id-type="pmid">12488331</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0157"><label>157</label><mixed-citation publication-type="journal" id="ame212477-cit-0157">
<string-name>
<surname>Krysko</surname>
<given-names>DV</given-names>
</string-name>, <string-name>
<surname>Mussche</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Leybaert</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>D'Herde</surname>
<given-names>K</given-names>
</string-name>. <article-title>Gap junctional communication and connexin43 expression in relation to apoptotic cell death and survival of granulosa cells</article-title>. <source>J Histochem Cytochem</source>. <year>2004</year>;<volume>52</volume>(<issue>9</issue>):<fpage>1199</fpage>&#x02010;<lpage>1207</lpage>.<pub-id pub-id-type="pmid">15314087</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0158"><label>158</label><mixed-citation publication-type="journal" id="ame212477-cit-0158">
<string-name>
<surname>Yin</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Yuan</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Luan</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>H</given-names>
</string-name>. <article-title>Restoring ovarian function with human placenta&#x02010;derived mesenchymal stem cells in autoimmune&#x02010;induced premature ovarian failure mice mediated by Treg cells and associated cytokines</article-title>. <source>Reprod Sci</source>. <year>2018</year>;<volume>25</volume>(<issue>7</issue>):<fpage>1073</fpage>&#x02010;<lpage>1082</lpage>.<pub-id pub-id-type="pmid">28954601</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0159"><label>159</label><mixed-citation publication-type="journal" id="ame212477-cit-0159">
<string-name>
<surname>Nakai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tatsumi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Arai</surname>
<given-names>M</given-names>
</string-name>. <article-title>Successive pregnancies in a patient with premature ovarian failure</article-title>. <source>Eur J Obstet Gynecol Reprod Biol</source>. <year>1984</year>;<volume>18</volume>(<issue>4</issue>):<fpage>217</fpage>&#x02010;<lpage>224</lpage>.<pub-id pub-id-type="pmid">6440817</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="ame212477-cit-0160">
<string-name>
<surname>Tung</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>CY</given-names>
</string-name>. <article-title>Immunologic basis of reproductive failure</article-title>. <source>Monogr Pathol</source>. <year>1991</year>;<volume>33</volume>:<fpage>308</fpage>&#x02010;<lpage>333</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="ame212477-cit-0161">
<string-name>
<surname>Kelkar</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Meherji</surname>
<given-names>PK</given-names>
</string-name>, <string-name>
<surname>Kadam</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Gupta</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Nandedkar</surname>
<given-names>TD</given-names>
</string-name>. <article-title>Circulating auto&#x02010;antibodies against the zona pellucida and thyroid microsomal antigen in women with premature ovarian failure</article-title>. <source>J Reprod Immunol</source>. <year>2005</year>;<volume>66</volume>(<issue>1</issue>):<fpage>53</fpage>&#x02010;<lpage>67</lpage>.<pub-id pub-id-type="pmid">15949562</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="ame212477-cit-0162">
<string-name>
<surname>Wassarman</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Litscher</surname>
<given-names>ES</given-names>
</string-name>. <article-title>The multifunctional zona pellucida and mammalian fertilization</article-title>. <source>J Reprod Immunol</source>. <year>2009</year>;<volume>83</volume>(<issue>1&#x02013;2</issue>):<fpage>45</fpage>&#x02010;<lpage>49</lpage>.<pub-id pub-id-type="pmid">19875177</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="ame212477-cit-0163">
<string-name>
<surname>Setiady</surname>
<given-names>YY</given-names>
</string-name>, <string-name>
<surname>Samy</surname>
<given-names>ET</given-names>
</string-name>, <string-name>
<surname>Tung</surname>
<given-names>KSK</given-names>
</string-name>. <article-title>Maternal autoantibody triggers De novo T cell&#x02010;mediated neonatal autoimmune disease1</article-title>. <source>J Immunol</source>. <year>2003</year>;<volume>170</volume>(<issue>9</issue>):<fpage>4656</fpage>&#x02010;<lpage>4664</lpage>.<pub-id pub-id-type="pmid">12707344</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="ame212477-cit-0164">
<string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, et&#x000a0;al. <article-title>Mesenchymal stem cell therapy using human umbilical cord in a rat model of autoimmune&#x02010;induced premature ovarian failure</article-title>. <source>Stem Cells Int</source>. <year>2020</year>;<volume>2020</volume>:<elocation-id>3249495</elocation-id>.<pub-id pub-id-type="pmid">32714395</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="ame212477-cit-0165">
<string-name>
<surname>Tong</surname>
<given-names>Z&#x02010;B</given-names>
</string-name>, <string-name>
<surname>Nelson</surname>
<given-names>LM</given-names>
</string-name>. <article-title>A mouse gene encoding an oocyte antigen associated with autoimmune premature ovarian failure</article-title>. <source>Endocrinology</source>. <year>1999</year>;<volume>140</volume>(<issue>8</issue>):<fpage>3720</fpage>&#x02010;<lpage>3726</lpage>.<pub-id pub-id-type="pmid">10433232</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="ame212477-cit-0166">
<string-name>
<surname>Kojima</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Prehn</surname>
<given-names>RT</given-names>
</string-name>. <article-title>Genetic susceptibility to post&#x02010;thymectomy autoimmune diseases in mice</article-title>. <source>Immunogenetics</source>. <year>1981</year>;<volume>14</volume>(<issue>1&#x02013;2</issue>):<fpage>15</fpage>&#x02010;<lpage>27</lpage>.<pub-id pub-id-type="pmid">7035348</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="ame212477-cit-0167">
<string-name>
<surname>Taguchi</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Nishizuka</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sakakura</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kojima</surname>
<given-names>A</given-names>
</string-name>. <article-title>Autoimmune oophoritis in thymectomized mice: detection of circulating antibodies against oocytes</article-title>. <source>Clin Exp Immunol</source>. <year>1980</year>;<volume>40</volume>(<issue>3</issue>):<fpage>540</fpage>&#x02010;<lpage>553</lpage>.<pub-id pub-id-type="pmid">6998618</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="ame212477-cit-0168">
<string-name>
<surname>Zhai</surname>
<given-names>QY</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Tian</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>Z</given-names>
</string-name>. <article-title>Review of psychological stress on oocyte and early embryonic development in female mice</article-title>. <source>Reprod Biol Endocrinol</source>. <year>2020</year>;<volume>18</volume>(<issue>1</issue>):<elocation-id>101</elocation-id>.<pub-id pub-id-type="pmid">33050936</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="ame212477-cit-0169">
<string-name>
<surname>Gore</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Attardi</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>DeFranco</surname>
<given-names>DB</given-names>
</string-name>. <article-title>Glucocorticoid repression of the reproductive axis: effects on GnRH and gonadotropin subunit mRNA levels</article-title>. <source>Mol Cell Endocrinol</source>. <year>2006</year>;<volume>256</volume>(<issue>1&#x02013;2</issue>):<fpage>40</fpage>&#x02010;<lpage>48</lpage>.<pub-id pub-id-type="pmid">16839661</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="ame212477-cit-0170">
<string-name>
<surname>Stephens</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Wand</surname>
<given-names>G</given-names>
</string-name>. <article-title>Stress and the HPA axis: role of glucocorticoids in alcohol dependence</article-title>. <source>Alcohol Res</source>. <year>2012</year>;<volume>34</volume>(<issue>4</issue>):<fpage>468</fpage>&#x02010;<lpage>483</lpage>.<pub-id pub-id-type="pmid">23584113</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="ame212477-cit-0171">
<string-name>
<surname>Xu</surname>
<given-names>YP</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Hong</surname>
<given-names>ZL</given-names>
</string-name>, et&#x000a0;al. <article-title>Psychological stressors involved in the pathogenesis of premature ovarian insufficiency and potential intervention measures</article-title>. <source>Gynecol Endocrinol</source>. <year>2024</year>;<volume>40</volume>(<issue>1</issue>):<elocation-id>2360085</elocation-id>.<pub-id pub-id-type="pmid">38813955</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="ame212477-cit-0172">
<string-name>
<surname>Xiang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Gou</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Chronic unpredictable mild stress&#x02010;induced mouse ovarian insufficiency by interrupting lipid homeostasis in the ovary</article-title>. <source>Front Cell Dev Biol</source>. <year>2022</year>;<volume>10</volume>:<fpage>933674</fpage>.<pub-id pub-id-type="pmid">36158217</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0173"><label>173</label><mixed-citation publication-type="journal" id="ame212477-cit-0173">
<string-name>
<surname>Ghatebi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Zavareh</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lashkarbolouki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Elahdadi</surname>
<given-names>SM</given-names>
</string-name>. <article-title>Implications from early life stress on the development of mouse ovarian follicles: focus on oxidative stress</article-title>. <source>J Obstet Gynaecol Res</source>. <year>2019</year>;<volume>45</volume>(<issue>8</issue>):<fpage>1506</fpage>&#x02010;<lpage>1514</lpage>.<pub-id pub-id-type="pmid">31207032</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0174"><label>174</label><mixed-citation publication-type="journal" id="ame212477-cit-0174">
<string-name>
<surname>Lu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ma</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Feng</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S</given-names>
</string-name>. <article-title>Current animal model systems for ovarian aging research</article-title>. <source>Aging Dis</source>. <year>2022</year>;<volume>13</volume>(<issue>4</issue>):<fpage>1183</fpage>&#x02010;<lpage>1195</lpage>.<pub-id pub-id-type="pmid">35855343</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0175"><label>175</label><mixed-citation publication-type="journal" id="ame212477-cit-0175">
<string-name>
<surname>Chon</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Umair</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yoon</surname>
<given-names>M&#x02010;S</given-names>
</string-name>. <article-title>Premature ovarian insufficiency: past, present, and future</article-title>. <source>Front Cell Dev Biol</source>. <year>2021</year>;<volume>9</volume>:<fpage>672890</fpage>.<pub-id pub-id-type="pmid">34041247</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0176"><label>176</label><mixed-citation publication-type="journal" id="ame212477-cit-0176">
<string-name>
<surname>Moolhuijsen</surname>
<given-names>LME</given-names>
</string-name>, <string-name>
<surname>Visser</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Anti&#x02010;M&#x000fc;llerian hormone and ovarian reserve: update on assessing ovarian function</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2020</year>;<volume>105</volume>(<issue>11</issue>):<fpage>3361</fpage>&#x02010;<lpage>3373</lpage>.<pub-id pub-id-type="pmid">32770239</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0177"><label>177</label><mixed-citation publication-type="journal" id="ame212477-cit-0177">
<string-name>
<surname>Abedy Ghehi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Fathi</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Abtahi</surname>
<given-names>N</given-names>
</string-name>, et&#x000a0;al. <article-title>Germ cells markers expression in mouse premature ovarian failure model</article-title>. <source>Pathobiol Rep</source>. <year>2019</year>;<volume>22</volume>(<issue>3</issue>):<fpage>149</fpage>&#x02010;<lpage>157</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0178"><label>178</label><mixed-citation publication-type="journal" id="ame212477-cit-0178">
<string-name>
<surname>Cedars</surname>
<given-names>MI</given-names>
</string-name>. <article-title>Evaluation of female fertility&#x02010;AMH and ovarian reserve testing</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2022</year>;<volume>107</volume>(<issue>6</issue>):<fpage>1510</fpage>&#x02010;<lpage>1519</lpage>.<pub-id pub-id-type="pmid">35100616</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0179"><label>179</label><mixed-citation publication-type="journal" id="ame212477-cit-0179">
<string-name>
<surname>Liu</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Xue</surname>
<given-names>J</given-names>
</string-name>, et&#x000a0;al. <article-title>Esculentoside a rescues granulosa cell apoptosis and folliculogenesis in mice with premature ovarian failure</article-title>. <source>Aging (Albany NY)</source>. <year>2020</year>;<volume>12</volume>(<issue>17</issue>):<fpage>16951</fpage>&#x02010;<lpage>16962</lpage>.<pub-id pub-id-type="pmid">32759462</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0180"><label>180</label><mixed-citation publication-type="journal" id="ame212477-cit-0180">
<string-name>
<surname>Cao</surname>
<given-names>LB</given-names>
</string-name>, <string-name>
<surname>Leung</surname>
<given-names>CK</given-names>
</string-name>, <string-name>
<surname>Law</surname>
<given-names>PW</given-names>
</string-name>, et&#x000a0;al. <article-title>Systemic changes in a mouse model of VCD&#x02010;induced premature ovarian failure</article-title>. <source>Life Sci</source>. <year>2020</year>;<volume>262</volume>:<elocation-id>118543</elocation-id>.<pub-id pub-id-type="pmid">33038381</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0181"><label>181</label><mixed-citation publication-type="journal" id="ame212477-cit-0181">
<string-name>
<surname>Puy</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Barroca</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Messiaen</surname>
<given-names>S</given-names>
</string-name>, et&#x000a0;al. <article-title>Mouse model of radiation&#x02010;induced premature ovarian insufficiency reveals compromised oocyte quality: implications for fertility preservation</article-title>. <source>Reprod Biomed</source>. <year>2021</year>;<volume>43</volume>(<issue>5</issue>):<fpage>799</fpage>&#x02010;<lpage>809</lpage>.</mixed-citation></ref><ref id="ame212477-bib-0182"><label>182</label><mixed-citation publication-type="journal" id="ame212477-cit-0182">
<string-name>
<surname>Long</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Wan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Don</surname>
<given-names>LF</given-names>
</string-name>. <article-title>DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer</article-title>. <source>Eur Rev Med Pharmacol Sci</source>. <year>2016</year>;<volume>20</volume>(<issue>6</issue>):<fpage>1087</fpage>&#x02010;<lpage>1092</lpage>.<pub-id pub-id-type="pmid">27049261</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0183"><label>183</label><mixed-citation publication-type="journal" id="ame212477-cit-0183">
<string-name>
<surname>Mauri</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gazouli</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Zarkavelis</surname>
<given-names>G</given-names>
</string-name>, et&#x000a0;al. <article-title>Chemotherapy associated ovarian failure</article-title>. <source>Front Endocrinol</source>. <year>2020</year>;<volume>11</volume>:<fpage>572388</fpage>.</mixed-citation></ref><ref id="ame212477-bib-0184"><label>184</label><mixed-citation publication-type="journal" id="ame212477-cit-0184">
<string-name>
<surname>Fleer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Brendel</surname>
<given-names>M</given-names>
</string-name>. <article-title>Toxicity, interstrand cross&#x02010;links and DNA fragmentation induced by &#x02018;activated&#x02019; cyclophosphamide in yeast: comparative studies on 4&#x02010;hydroperoxy&#x02010;cyclophosphamide, its monofunctional analogon, acrolein, phosphoramide mustard, and nor&#x02010;nitrogen mustard</article-title>. <source>Chem Biol Interact</source>. <year>1982</year>;<volume>39</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02010;<lpage>15</lpage>.<pub-id pub-id-type="pmid">7037214</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0185"><label>185</label><mixed-citation publication-type="journal" id="ame212477-cit-0185">
<string-name>
<surname>Jarrell</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Bodo</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>YoungLai</surname>
<given-names>EV</given-names>
</string-name>, <string-name>
<surname>Barr</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>O'Connell</surname>
<given-names>GJ</given-names>
</string-name>. <article-title>The short&#x02010;term reproductive toxicity of cyclophosphamide in the female rat</article-title>. <source>Reprod Toxicol</source>. <year>1991</year>;<volume>5</volume>(<issue>6</issue>):<fpage>481</fpage>&#x02010;<lpage>485</lpage>.<pub-id pub-id-type="pmid">1810575</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0186"><label>186</label><mixed-citation publication-type="journal" id="ame212477-cit-0186">
<string-name>
<surname>Kitanohara</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Masunaga</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ohishi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Komatsu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nagase</surname>
<given-names>M</given-names>
</string-name>. <article-title>Effect of porcine placental extract on the mild menopausal symptoms of climacteric women</article-title>. <source>Climacteric</source>. <year>2017</year>;<volume>20</volume>(<issue>2</issue>):<fpage>144</fpage>&#x02010;<lpage>150</lpage>.<pub-id pub-id-type="pmid">28112981</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0187"><label>187</label><mixed-citation publication-type="journal" id="ame212477-cit-0187">
<string-name>
<surname>Zhang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, et&#x000a0;al. <article-title>The comparison of animal models for premature ovarian failure established by several different source of inducers</article-title>. <source>Regul Toxicol Pharmacol</source>. <year>2016</year>;<volume>81</volume>:<fpage>223</fpage>&#x02010;<lpage>232</lpage>.<pub-id pub-id-type="pmid">27612992</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0188"><label>188</label><mixed-citation publication-type="journal" id="ame212477-cit-0188">
<string-name>
<surname>Yao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>. <article-title>Protective roles and mechanisms of rosmarinic acid in cyclophosphamide&#x02010;induced premature ovarian failure</article-title>. <source>J Biochem Mol Toxicol</source>. <year>2020</year>;<volume>34</volume>(<issue>12</issue>):<elocation-id>e22591</elocation-id>.<pub-id pub-id-type="pmid">32711407</pub-id>
</mixed-citation></ref><ref id="ame212477-bib-0189"><label>189</label><mixed-citation publication-type="journal" id="ame212477-cit-0189">
<string-name>
<surname>Xing</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ding</surname>
<given-names>Z</given-names>
</string-name>, et&#x000a0;al. <article-title>Protective effect and mechanism of melatonin on cisplatin&#x02010;induced ovarian damage in mice</article-title>. <source>J Clin Med</source>. <year>2022</year>;<volume>11</volume>(<issue>24</issue>):<fpage>7383</fpage>.<pub-id pub-id-type="pmid">36555999</pub-id>
</mixed-citation></ref></ref-list></back></article>